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4.3 Scatterplots of ÂUC(γˆopt) vs. αˆopt for m = 1000 assuming AUC∗ = 0.965 . 63
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6.5 Unknown variance: Scatterplots of ÂUC(γˆopt) vs. αˆopt for m = 1000 . . . . 89
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1 Preface
1.1 Introduction
In gene expression or proteomic studies large numbers of variables are investigated. We
generally can not assume that a few of the investigated variables show noticeable ef-
fects. Instead we often hope that there is at least a combination of several variables
which, e.g., allow a prediction of the response of an individual patient to a particular
therapy. The task of selecting useful variables with rather moderate eﬀects from a very
large number of candidates and estimating suitable scores to be used for the prediction of
a clinical outcome (e.g. success of a speciﬁc therapy) in future patients is a hard exercise.
Moreover, due to limited resources generally small sample sizes per variable are available
which makes the problem even less tractable. For medical research reported in this ﬁeld
there is not always suﬃcient awareness of the statistical properties of the resulting prog-
nostic scores. For instance, Ntzani and Ioannidis (2003) showed for prediction of cancer
outcome that the constructed scores are poorly performing in external validation samples.
Subset selection procedures (e.g. Shao (1993), Miller (2002)) are widely used for such
type of problem. However, there is a general problem of how to quantify the probability
for falsely selecting variables not related to the clinical outcome. There have been pro-
posals of estimating the positive false discovery rate in case that a nonzero model has
been selected (Li and Hui (2007)). It is known that model selection by multiple testing of
individual model parameters under fairly general conditions asymptotically is a consistent
selection procedure: for increasing sample size the critical boundary for the univariate test
statistics (the parameter estimate divided by its standard error) has to approach inﬁnity
at a smaller order than the inverse of the standard error (Bauer et al. (1988)). Asymptotic
relationships between model selection procedures and multiple tests controlling the false
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discovery rate, i.e. the expected proportion of type I errors among all rejected hypotheses
(FDR, see Benjamini and Hochberg (1995)), have been shown (Abramovich et al. (2006)).
However such asymptotic results do not help how to tune the multiple test procedure in
a speciﬁc sample in order to achieve good prediction of the outcome of a future patient.
1.2 Investigated problem
In this thesis we consider the following scenario: we want to search for predictors of a
binary outcome (e.g. success of a therapy) among a large set of candidate variables (e.g.
genes, proteins). Independent samples of patients responding and non-responding to the
therapy are available (case-control study). Based on the given samples variables have to
be selected and a score has to be constructed which will be used to predict response to
therapy in future patients. The candidate variables are assumed to follow normal distri-
butions.
We consider multiple tests controlling the false discovery rate (FDR) for the selection
of variables. A linear score is estimated from the selected variables and its performance is
assessed in terms of the statistical properties of the resulting receiver operating character-
istic curve (ROC-curve). The area under the ROC-curve (AUC), a widely used measure
how well a score can predict the clinical outcome is calculated varying the FDR level for
selection, the number of candidate variables, per-group sample sizes and the number of
prognostic variables related with the clinical outcome (alternatives).
We demonstrate that the threshold for the FDR which achieves the maximal AUC largely
varies between diﬀerent parameter constellations. Therefore we propose that cross vali-
dation is used to determine the FDR for the test based selection procedure optimal with
regard to the AUC. It is investigated to what extend this optimization has an impact on
the resulting FDR of the multiple test procedure.
A further typical data analytic approach used for such type of problem is the binary
logistic regression. For comparison to the multiple test procedure we additionally inves-
tigate what can be achieved in terms of the AUC by using a stepwise (forward) binary
2
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logistic regression model for selecting variables and building a linear prediction score.
1.3 Outline of the thesis
This work is a continuation of the second part of my doctoral thesis in Statistics (A084
136) where the described procedures were only investigated under the simple assumptions
of independence across hypotheses and known variance (compare Goll (2008)). In this
diploma thesis, after a repetition of the results assuming the simple assumptions addition-
ally a more sophisticated method to determine the optimal FDR has been used, another
form of the cross validation procedure (using the mean diﬀerence in the score values)
and extensions to the two-sided test situation as well as to the case of unequal eﬀect
sizes are discussed. Furthermore, results with respect to deviations from the underlying
assumptions as unknown variance and correlation between hypotheses are investigated.
Additionally the cross validation procedure is investigated for four real data sets.
First, an introduction to the general methodology is given in Chapter 2. Chapter 3
gives an overview of some results under the simple assumptions of independence across
variables and known variance. Section 3.1 describes the basic assumptions, in Section 3.2
the selection methods (multiple test controlling the FDR and the binary logistic regres-
sion) are introduced and in Section 3.3 we explain the construction of a simple prediction
score based on the selection methods. The results of the simulation studies for the mul-
tiple testing procedure for diﬀerent parameter constellations can be seen in Section 3.5.
Selection and prediction using a forward logistic regression model is discussed in Section
3.6. The situation under the global null hypothesis is described in Section 3.7. Using
cross validation to determine selection boundaries for the multiple testing procedure by
optimizing the AUC is discussed in Section 4 (compare also Goll (2008)). Chapter 5 gives
some extensions as the two-sided test situation (Section 5.1) and the situation of unequal
eﬀect sizes (Section 5.2) among the alternatives again assuming independence across vari-
ables and known variance. Chapter 6 presents the results for the situation of unknown
variances. The diﬀerences of the selection procedure and the prediction score as compared
to the known variance case are discussed in Sections 6.1 and simulation results are given
in Section 6.2. The cross validation procedure for the unknown variance case is discussed
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in Section 6.3. The situation of an autoregressive correlation structure between variables
is discussed in Chapter 7. Selection of variables and the corresponding changes in the
prediction score are discussed in Section 7.1. The corresponding simulation studies are
given in Section 7.2. The cross validation procedure under the assumption of correlated
hypotheses is discussed in Section 7.3. In Chapter 8 the investigated cross validation
procedure is applied for four example data sets. A short discussion of the results is given
in Chapter 9.
1.4 Publications
As mentioned above, this work is a continuation of the second part of my doctoral thesis:
Goll (2008): Inference on a large number of hypotheses based on limited samples -
some points to consider.
This thesis is based on the following submitted paper:
Goll and Bauer (2008): Model selection based on the false discovery rate optimizing
the area under the receiver operating characteristic curve.
A few results have been used and cited in
Bauer (2008): Adaptive designs: looking for a needle in the haystack - a new chal-
lenge in medical research, Statistics in Medicine, 27: 1565-1580.
1.5 Availability
An R-program (R (2005)) for the cross validation procedure is available on:
http://statistics.msi.meduniwien.ac.at/index.php?page=page_ag_publications
These R-program can also be seen in the appendix.
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2.1 Properties of the normal distribution
As mentioned in the preface, in this thesis we assume that the observed candidate variables
(e.g. gene expression data or protein volumes) are normal distributed. In the following
some important properties of the normal distribution, which may be used later in the
thesis, are discussed. The given deﬁnitions, theorems and the corresponding proofs can
be seen in e.g. Sachs (1999) and Anderson (2003).
Deﬁnition 2.1.0.1 A random variable X is normal distributed with mean value µ and
variance σ2 (standard deviation σ) if the corresponding density is given as:
f(x | µ, σ) = 1
σ
√
2pi
exp
−12
[
(x− µ)
σ
]2 .
This distribution is denoted by N [µ, σ2].
Note that the turning points of f(x | µ, σ) are µ − σ and µ + σ. Approximately 2/3 of
all observations are lying within the two turning points. Note also that the mean value µ
and the variance σ2 are estimated by the sample mean
x¯ =
1
n
n∑
i=1
xi
and the empirical variance
s2 =
1
n− 1
n∑
i=1
(xi − x¯)2.
Theorem 2.1.0.1 X¯ and S2 are stochastically independent.
Deﬁnition 2.1.0.2 The normal distribution with mean value µ = 0 and variance σ2 = 1
is denoted as standard normal distribution (N [0, 1]) with density:
f(z) =
1√
2pi
exp(
−z2
2
)
5
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Theorem 2.1.0.2 Let X be a random variable distributed according to N [µ, σ2]. The
random variable
Z =
X − µ
σ
is standard normal distributed (Z ∼ N [0, 1]).
Theorem 2.1.0.3 The cumulative distribution function of the standard normal distribu-
tion can be calculated as:
Φ(z) = P [Z ≤ z] = 1√
2pi
∫ z
−∞
exp(
−v2
2
)dv
In the thesis we may refer to the following properties of the standard normal distribution:
Theorem 2.1.0.4 Properties of the standard normal distribution (N [0, 1]):
• Because of the symmetry of the normal distribution:
Φ(−z) = 1− Φ(z)
• P [| Z |≤ z] = 2Φ(z)− 1 and P [| Z |> z] = 2(1− Φ(z))
Typical properties of the normal distribution (N [µ, σ2]) are summarized in the next the-
orem.
Theorem 2.1.0.5 Let Xi ∼ N [µ, σ2] for i = 1, ..., n, then
• ∑ni=1Xi ∼ N [nµ, nσ2]
• 1
n
∑n
i=1Xi ∼ N [µ, σ2/n]
• Xi−µ
σ
∼ N [0, 1]
• X¯−µ
σ
√
n ∼ N [0, 1]
• ∑ni=1(Xi−µσ )2 ∼ χ2v chi-square distributed with v = n degrees of freedom
• S2/σ2(n−1) = 1
σ2
∑n
i=1(Xi−X¯n)2 ∼ χ2v chi-square distributed with v = n−1 degrees
of freedom
The normal distribution also plays an important role for the approximation of other
distributions.
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Theorem 2.1.0.6 Central limit theorem: Let Sn =
∑n
i=1Xi be the sum of n indepen-
dent identical distributed random variables with the same expected value µ and the same
variance σ2 and let
S∗n =
Sn − nµ
σ
√
n
be the corresponding standardized random variable, then
lim
n→∞P [S
∗
n ≤ z] = Φ(z)
(convergence in distribution).
When moving to more than one candidate variable we need the following deﬁnition:
Deﬁnition 2.1.0.3 Let X = (X1, ..., Xm) be random variables. The common distribu-
tion is called a m-dimensional multivariate normal distribution with mean vector µ and
covariance matrix Σ if the density is of the form:
f(x) =
1
(2pi)m/2det(
∑
)1/2
exp
[
−1
2
(x− µ)T ∑−1(x− µ)]
with Σ positive deﬁnite. We denote this distribution by N [µ,Σ].
One important property of the m-dimensional normal distribution used in the thesis is:
Theorem 2.1.0.7 If the m-dimensional random vector X = (X1, ..., Xm) is distributed
according to N [µ,Σ] then each linear combination with weights cT = (c1, ..., cm)
Y = cTX =
m∑
i=1
ciXi
is distributed according to N [cTµ, cTΣc].
2.2 Measures of accuracy for binary tests
Classiﬁcation and prediction are fundamental components of clinical practice, e.g. a pa-
tient should be classiﬁed as a responder to a speciﬁc treatment or not. Classiﬁcation errors
can lead to serious consequences in medicine, e.g. a patient who would in fact response to
the therapy but who was erroneously classiﬁed as non-responder may not receive the vital
treatment. A patient who would in fact not response to the therapy but was erroneously
classiﬁed as a responder will at a minimum undergo unnecessary medical procedures and
7
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emotional stress. The accuracy of such a diagnostic test that classiﬁes a subject as either
responder or non-responder can be deﬁned in various ways discussed in the following. The
given deﬁnitions, theorems and the corresponding proofs can be seen in Pepe (2003).
Let the binary variable R denote the true response status of a patient:
R =
{
1 for response
0 for non-response
. (2.1)
The variable Y denotes the result of a diagnostic test:
Y =
{
1 positive for response
0 negative for response
. (2.2)
If we know the truth, the result of the test can than be classiﬁed as true positive, true
negative, false positive or false negative. Hence, the test can have two types of errors,
false positive errors and false negative errors.
Deﬁnition 2.2.0.4 Classiﬁcation probabilities:
• false positive fraction= FPF = P [Y = 1 | R = 0]
• true negative fraction= TNF = P [Y = 0 | R = 0] = 1− FPF
• true positive fraction= TPF = P [Y = 1 | R = 1]
• false negative fraction= FNF = P [Y = 0 | R = 1] = 1− TPF
TPF and TNF are also known as sensitivity and speciﬁcity.
Because FNF = 1 − TPF the pair (FPF, TPF ) deﬁnes the probabilities with which
errors occur when using the given test. An ideal test clearly has FPF = 0 and TPF = 1.
For a useless test on the other had, i.e. if response to therapy has no relation to the test
outcome, TPF = FPF . Note that in context of statistical hypothesis testing of a null
hypothesis (R = 0) versus an alternative hypothesis (R = 1) the terms signiﬁcance level
(α = FPF ) and statistical power (1− β = TPF ) are used (see next Section 2.3).
As an alternative, accuracy can be quantiﬁed by how well a test result predicts true
response status.
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Deﬁnition 2.2.0.5 The predictive values are:
• positive predictive value= PPV = P [R = 1 | Y = 1]
• negative predictive value= NPV = P [R = 0 | Y = 0]
Thus a perfect test will predict response perfectly with PPV=1 and NPV=1. On the
other hand a useless test has no information about true response status and thus P [R =
1 | Y = 1] = P [R = 1] and P [R = 0 | Y = 0] = P [R = 0]. We see that the predictive
values depend not only on the performance of the test in responding and non-responding
patients, but also on the prevalence of response. A low PPV may simply be a result
of low prevalence of response or it may be due to a test that does not reﬂect the true
response status of the patient very well. The classiﬁcation probabilities, TPF and FPF,
are considered more relevant to quantify the inherent accuracy of the test because they
quantify how well the test reﬂects true response status. There is a direct relationship
between predictive values and the classiﬁcation probabilities.
Theorem 2.2.0.8 Let ν = P [R = 1] and τ = P [Y = 1] then
• PPV = νTPF/(νTPF + (1− ν)FPF )
• NPV = (1− ν)(1− FPF )/((1− ν)(1− FPF ) + ν(1− TPF ))
• τ = νTPF + (1− ν)FPF
• TPF = τPPV/(τPPV + (1− τ)(1−NPV ))
• FPF = τ(1− PPV )/(τ(1− PPV ) + (1− τ)NPV )
• ν = τPPV + (1− τ)(1−NPV )
Likelihood ratios are a further way of describing the prognostic or diagnostic value of a
test.
Deﬁnition 2.2.0.6 Diagnostic likelihood ratios (DLR) are deﬁned as:
• positive DLR=DLR+ = P [Y = 1 | R = 1]/P [Y = 1 | R = 0]
• negative DLR=DLR− = P [Y = 0 | R = 1]/P [Y = 0 | R = 0]
They are the ratios of the likelihood of the observed test result in the responding versus
the non-responding populations. An uninformative test having no relation to response
9
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status has DLRs of unity. On the other hand, a perfect test, for which Y = R with prob-
ability 1 has DLR parameters DLR+ =∞ and DLR− = 0. A DLR+ > 1 indicates that
a positive test is more likely in a responding subject than in a non-responding subject.
Similarly with DLR− ≤ 1.
Consider now the odds that a subject response to therapy before the test is performed,
i.e. in absence of the test result.
Deﬁnition 2.2.0.7 The pre-test odds are deﬁned as:
pre− test odds = P [R = 1]
1− P [R = 1] =
P [R = 1]
P [R = 0]
After the test is performed, i.e. with knowledge of the test results, the odds of response
are:
Deﬁnition 2.2.0.8 The post-test odds are deﬁned as:
post− test odds(Y = y) = P [R = 1 | Y = y]
P [R = 0 | Y = y]
where y = 0 or 1.
Some relationships between DLRs, predictive values, classiﬁcation probabilities and odds
are discussed in the following .
Theorem 2.2.0.9 The following results hold:
• post-test odds (Y=1)= DLR+× (pre-test odds)
• post-test odds (Y=0)= DLR−× (pre-test odds)
Theorem 2.2.0.10 The following results hold:
• post-test odds (Y=1)=PPV /(1-PPV)
• post-test odds (Y=0)=(1-NPV)/ NPV
Theorem 2.2.0.11 The following results hold:
• DLR+ = TPF/FPF
• DLR− = (1− TPF )/(1− FPF )
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A single index of classiﬁer performance commonly used in medicine is the odds ratio (ratio
of post-test odds).
Theorem 2.2.0.12 The odds ratio can be written as:
OR =
post− test odds(Y = 1)
post− test odds(Y = 0) = DLR
+ 1
DLR−
=
=
PPV
(1− PPV )
NPV
(1−NPV ) =
TPF
FPF
(1− FPF )
(1− TPF )
A single odds ratio value can result from a wide variety of classiﬁcation performances
(FPF, TPF ). For example an odds ratio of 36 results from (FPF = 0.1, TPF = 0.8)
which might be considered "good" classiﬁcation or from (FPF = 0.5, TPF = 0.973)
which is likely considered "poor" classiﬁcation (see e.g. Pepe and Thompson (2002),
Pepe et al. (2004)).
2.3 Multiple tests controlling the false discovery rate
2.3.1 Error rates for multiple testing
Binary responses are commonly studied in medical and epidemiologic research, e.g. the
response to a particular therapy. To ﬁnd the variables related to the clinical outcome
among a large set of candidate genes one may apply a multiple test procedure.
As mentioned in the last section, when a single null hypotheses H is tested, a type I
error, that is rejecting the hypotheses, when it is in fact true (a false positive decision)
may occur. A standard approach is to specify an acceptable level α for the probability
of a type I error (signiﬁcance level). Let H = 0 if the null hypotheses is in fact true, and
H = 1 if the alternative holds. The control of a speciﬁed type I error probability α can
be achieved by choosing a critical value cα such that P [T ≥ cα | H = 0] ≤ α, where T
is the corresponding test statistic for hypothesisH. The hypothesisH is rejected if T ≥ cα.
If the hypothesis is accepted, although in fact the alternative holds, a type II error occurs
(a false negative decision). The probability of a type II error is: β = P [T < cα | H = 1].
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Table 2.1: Possible outcomes after a multiple testing procedure
Number of not rejected rejected Total
True null hypotheses TN FP mpi0 = m−me
False null hypotheses FN TP m(1− pi0) = me
Total m-R R m
Multiple testing refers to the testing of more than one hypothesis at the same time.
For example in gene expression or proteomic studies thousands of hypotheses are tested
simultaneously. Since the probability of at least one type I error increases with the num-
ber of hypotheses, in such studies large multiplicity problems occur. Table 2.1 shows
the possible outcome after a multiple testing procedure. Consider the problem of testing
simultaneously m null hypotheses Hi, i = 1, ...,m and denote by R the number of rejected
hypotheses among the m hypotheses. Assume that there are mpi0(= m −me) true null
hypotheses among all m hypotheses. The proportion of true null hypotheses pi0 is an
unknown parameter. The number of rejected hypotheses R is an observed random vari-
able and TP (number of true positive decisions), FN (number of false negative decisions),
TN (number of true negative decisions) and FP (number of false positive decisions) are
unobservable random variables.
Two common error rates used to control the type I error are:
Deﬁnition 2.3.1.1 The Family Wise Error Rate (FWER) is deﬁned as the proba-
bility of at least one type I error:
FWER = P [FP ≥ 1],
were FP is the number of rejected true null hypotheses (false positives).
Deﬁnition 2.3.1.2 The False Discovery Rate (FDR) is the expected proportion of
type I errors among the rejected hypotheses:
FDR = E
[
FP
R
| R > 0
]
P (R > 0) = E
[
V
max(R, 1)
]
where FP is the again the number of false positives and R denotes the number of rejected
hypotheses. The eﬀect max(R, 1) in the denominator is to set FP/R = 0 if R = 0
(compare Benjamini and Hochberg (1995)).
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A multiple testing procedure is said to control a particular type I error rate at level α
if this error rate is less than or equal to α. There is a distinction between strong and
weak control of a type I error rate. Strong control refers to the control of the type I error
rate under any combination of true and false null hypotheses. In contrast, weak control
refers to the control of the type I error rate only under the global null hypothesis, that
is when all null hypotheses are in fact true. Weak control is unsatisfactory, because in
reality, some null hypotheses may be true and others false, but the subset of true null
hypotheses is unknown. Strong control ensures that the type I error rate is controlled
under the unknown combination of true and false null hypotheses.
The following properties of the FDR were shown in Benjamini and Hochberg (1995):
Theorem 2.3.1.1 Properties of the FDR:
• Under the complete null hypotheses (if all null hypotheses are true: me = 0), the
FDR is equivalent to the FWER. Therefore control of the FDR implies control of
the FWER in the weak sense.
• If pi0 < 1, the FDR is smaller than or equal to the FWER.
As a result of theorem 2.3.1.1, any procedure that controls the FWER also controls the
FDR. Procedures that control the FWER are more conservative, that is, lead to fewer
rejections than those controlling the FDR. If a procedure only controls the FDR, more
type I errors but less type II errors occur and thus, the power of the procedure may be
increased. In the long run there is always a fraction of at most α true null hypotheses
among the rejected hypotheses.
Within the class of multiple testing procedures that control a given type I error rate
at an acceptable level α, one seeks for test procedures that maximize the power (1− β),
that is, minimize the type II error rate (β). As with type I error rates, the concept of
power can be generalized when moving from single to multiple hypotheses testing.
Deﬁnition 2.3.1.3 Under the assumption of a common alternative (as considered in the
13
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following) the power is the expected fraction of null hypotheses correctly rejected
1− β = E[TP ]
me
=
E[TP ]
m(1− pi0) .
2.3.2 Procedures controlling the FDR
In the genomic or proteomic setting, where thousands of tests are performed simulta-
neously and only a small number of genes or proteins are expected to be diﬀerentially
expressed, FDR controlling procedures present a promising alternative to FWER ap-
proaches (as e.g. the Bonferroni correction or the Bonferroni-Holm procedure). In such
situations, controlling the FWER can lead to unduly conservative procedures. One may
tolerate some type I errors, provided their number is small in comparison to the number
of rejected hypotheses. The FDR oﬀers a less strict multiple testing criterion than the
FWER.
Two approaches to provide FDR controlling procedures are the following: One is to ﬁx
the acceptable FDR level beforehand, and ﬁnd a data-dependent thresholding rule so that
the FDR of this rule is less than or equal to the pre-chosen level. This is the approach
taken by Benjamini and Hochberg (1995). Another is to ﬁx the thresholding rule and
form an estimate of the FDR whose expectation is greater than or equal to the true FDR
over that signiﬁcance region. This is the approach taken by Storey (2002). These two
procedures are discussed in the following.
The Benjamini-Hochberg procedure
Benjamini and Hochberg (1995) derived the following step-up procedure for strong control
of the FDR for independent test statistics. In contrast to step-down procedures, step-
up procedures begin with the largest p-value. Benjamini and Hochberg proved that the
following procedure controls the FDR at a pre-chosen level α when the p-values following
the null distribution are independent and uniformly distributed.
Deﬁnition 2.3.2.1 The method of Benjamini and Hochberg proceeds as follows:
1. Let p1 ≤ ... ≤ pm denote the observed ordered p-values corresponding to the hypothe-
ses H1, ..., Hm.
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2. For the control of the FDR at level α calculate
kˆ = max{1 ≤ k ≤ m : pk ≤ kmα}.
3. If kˆ exists, then reject the null hypotheses Hj for j = 1, ..., kˆ corresponding to
p1 ≤ ... ≤ pkˆ. Otherwise, reject nothing.
Theorem 2.3.2.1 For independent test statistics and for any conﬁguration of false null
hypotheses, the above procedure controls the FDR at level α.
The proof of theorem 2.3.2.1 can be found in Benjamini and Hochberg (1995). It was also
shown by Storey, Taylor and Siegmund (2004) that the Benjamini-Hochberg procedure
controls the FDR in the strong sense. Benjamini and Yekutieli (2001) proved that this
procedure also controls the FDR when the test statistics have positive dependency on
each of the test statistics corresponding to the true null hypothesis. They also proposed,
referring to Hommel (1988), a simple conservative modiﬁcation of the procedure, replac-
ing αk/m with αk/(m
∑m
j=1
1
j
) in the second step, which provides FDR control under
arbitrary dependence structures (see also Dudoit et al. (2003)).
The Benjamini-Hochberg procedure was originally introduced by Simes (1986) to weakly
control the FWER when all p-values are independent, although it happens to provide
strong control of the FDR.
Storey’s procedure
As mentioned before, instead of ﬁxing α and estimating the rejection region, Storey (2002)
ﬁxed the rejection region and then estimated the FDR. Storey's method uses informa-
tion about pi0, which yields a less stringent procedure and more power, while maintaining
strong control. Typically the power of a multiple test procedure decreases with increasing
m. But the larger m, the more information about pi0 is obtained.
Again m identical hypothesis tests H1, ..., Hm are performed with independent test statis-
tics T1, ..., Tm. Let Hi = 0 when the null hypothesis i is true and Hi = 1 otherwise. It is
assumed that the test statistics under the true null Ti|(Hi = 0) and under the alternative
hypothesis Ti|(Hi = 1) are identically distributed. It is further assumed that the same
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rejection region is used for each test. Finally it is assumed, that the Hi are independent
Bernoulli random variables with P [Hi = 0] = pi0 and P [Hi = 1] = 1− pi0 = pi1. Let Γ be
the common rejection region for each hypothesis test.
Theorem 2.3.2.2 Under the above assumptions the FDR can be written as:
FDR = P [H = 0 | T ∈ Γ] = pi0P [T ∈ Γ | H = 0]
pi0P [T ∈ Γ | H = 0] + pi1P [T ∈ Γ | H = 1]
=
pi0P [T ∈ Γ | H = 0]
P [T ∈ Γ] (2.3)
In the following hypotheses are rejected on the basis of independent p-values. For re-
jections based on p-values, all rejection regions are of the form [0, γ] for some γ ≥ 0.
Theorem 2.3.2.3 In terms of p-values the above result can be written as:
FDR(γ) =
pi0P [p ≤ γ | H = 0]
P [p ≤ γ] =
pi0γ
P [p ≤ γ] (2.4)
where p is the random p-value resulting from any test.
Since pi0 is an unknown parameter, it has to be estimated. Storey (2002) proposed the
following conservative estimate of pi0:
Deﬁnition 2.3.2.2 The proportion of true null hypotheses pi0 is estimated by:
pˆi0(λ) =
]{pi > λ}
(1− λ)m =
W (λ)
(1− λ)m (2.5)
for some well-chosen λ, where p1, ..., pm are the observed p-values, and W (λ) = ]{pi > λ}
is the number of observed p-values exceeding λ. For a small proportion of null hypotheses
this estimator can be larger than 1, thus in this cases it is set to 1.
The argument for the choice of the estimator pˆi0(λ) he explained as follows: As long as
each test has reasonable power the large p-values are most likely to come from the true
null hypothesis. Therefore for a well chosen λ, it is expected, that pi0(1 − λ) of the p-
values lie in the interval (λ, 1], because the p-values under the true null hypotheses are
uniformly distributed. Therefore W (λ)/m ≈ pi0(1 − λ), where E[pˆi0(λ)] ≥ pi0 when the
p-values corresponding to the true null hypotheses are uniformly distributed.
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There is an inherent bias-variance trade oﬀ in the choice of λ. When λ gets smaller,
the bias of pˆi0 gets larger, but the variance gets smaller. Choosing a larger λ reduces the
bias at the cost of higher variance (Storey et al. (2004)). Therefore, λ can be chosen to try
to balance this trade-oﬀ. Storey (2002) optimized the value for λ to minimize the mean
squared error of the estimate with bootstrap methods. However, simulations showed that
when choosing a non-optimal λ the diﬀerence in their true mean-squared errors is not
very drastic. For his calculations he used λ = 0.5. For our calculations we will also use
λ = 0.5
It is now assumed that λ is ﬁxed.
Deﬁnition 2.3.2.3 An estimate of P [p ≤ γ] is:
P̂ [p ≤ γ] = ]{pi ≤ γ}
m
=
R(γ)
m
where R(γ) = ]{pi ≤ γ}.
Theorem 2.3.2.4 The estimate for the FDR can be calculated as:
̂FDRλ(γ) = pˆi0(λ)γ
P̂ (p ≤ γ) =
W (λ)γ
(1− λ) max{R(γ), 1} (2.6)
If ̂FDRλ(γ) > 1 Storey suggest setting ̂FDRλ(γ) = 1.
The following important result was proven by Storey, Taylor and Siegmund (2004).
Theorem 2.3.2.5 Suppose that the p-values corresponding to the true null hypotheses
are independent and uniformly distributed. Then for ﬁxed λ ∈ [0, 1):
E[ ̂FDRλ(γ)] ≥ FDR(γ)
for all γ and pi0 < 1.
Note that Storey (2002) ﬁxed a rejection boundary γ and proposed an estimator for the
FDR. To perform a test controlling a pre-chosen FDR α, the largest γ has to be deter-
mined, such that ̂FDRλ(γ) ≤ α. For λ = 0 Storey's procedure for a pre-chosen FDR
is equivalent to the Benjamini-Hochberg procedure. For λ > 0, the rejection boundary
γ is larger compared to the Bejamini-Hochberg method and thus it may be more powerful.
The following theorem may also be used in the thesis:
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Theorem 2.3.2.6 Asymptotically, for m→∞ the FDR can be written as:
α =
pi0γ
pi0γ + (1− pi0)(1− β(γ))
where (1− β(γ)) is the power and β(γ) is the type II error as a function of the rejection
boundary γ.
2.4 Linear methods for classification
2.4.1 Binary logistic regression
In medical research it is often studied how a set of predictor variablesX = (X1, X2, ..., Xm)
is related to a dichotomous response variable R. Note that the true response is deﬁned
by R = 0 if a patient does not response or 1 if a patient responds to a speciﬁc therapy.
The statistical model that is generally preferred for the analysis of binary responses is the
binary logistic regression model (see e.g. Harrel (2001), Hastie et al. (2001)).
Deﬁnition 2.4.1.1 The binary logistic regression model is stated in terms of the proba-
bility that R = 1 given X, the values of the predictors:
P [R = 1 | X = x] = [1 + exp(−xβ)]−1
where xβ = β0 + β1x1 + β2x2 + ...+ βmxm.
Deﬁnition 2.4.1.2 The function q = [1+exp(−x)]−1 is called the logistic function. Note
that this function has an unlimited range for x but q is restricted to range from 0 to 1.
Solving the equation above for x by using
1− q = exp(−x)/[1 + exp(−x)]
yields the inverse of the logistic function
x = log[
q
1− q ] = logit(R = 1 | X = x)
Note that q
1−q is the odds ratio that R = 1 occurs. Since the logistic model is stated in
terms of q = P [R = 1 | X = x] its only assumptions relate to the form of the regression
equation. We transform P [R = 1] to make a model that is linear in xβ:
logit(R = 1 | X = x) = logit(q) = log[ q
1− q ] = xβ
18
2.4 Linear methods for classiﬁcation
where q = P [R = 1 | X = x]. Thus the model is a linear regression model in the log odds
that R = 1 since logit(q) is a weighted sum of x.
The parameter βj is then the change in the log odds per unit change in xj if xj rep-
resents a single factor that is linear and does not interact with other factors and if all
other factors are held constant. Instead of writing this relation ship in terms of log odds,
it could just as easily be written in terms of the odds that R = 1.
odds{R = 1 | X = x} = exp(xβ)
The eﬀect of increasing xj by d is to increase the odds that R = 1 by a factor of exp(βjd)
or to increase the log odds that R = 1 by an increment βjd. The logistic model quantiﬁes
the eﬀect of a predictor in terms of an odds ratio or log odds ratio.
The parameters in the logistic regression model are estimated using the maximum like-
lihood method. Denoting the response and vector of predictors of response of the ith
subject by Ri and xi, respectively, the model states that qi = P [Ri = 1 | X = xi] =
[1 + exp(−xiβ)]−1. The likelihood of an observed responder Ri given predictors xi and
the unknown parameter vector β is
qRii [1− qi]1−Ri .
The joint likelihood of all responses Ri, i = 1, ..., n is the product of theses likelihoods:
L(β) =
n∏
i=1
qRii [1− qi]1−Ri
Thus, the log likelihood is:
log(L(β)) =
n∑
i=1
Ri log(qi) + (1−Ri) log(1− qi)
=
n∑
i=1
Ri log(
qi
1− qi ) + log(1− qi)
=
n∑
i=1
Rilogit(qi)− log(1 + exp(logit(qi))).
The likelihood and log likelihood functions are rewritten by using the deﬁnition of qi above
to allow them to be recognized as a function of the unknown parameters β. Note that
βˆ cannot be written explicitly. The Newton-Raphson method is usually used to salve
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iteratively for the list of values β that maximize the log likelihood.
Since the maximum likelihood estimate of a function of a parameter is the same function
of the maximum likelihood estimate if the parameter:
qˆi = [1 + exp(−xiβˆ)]−1.
To test the null hypotheses H0 : βi = 0 against the alternative H1 : βi 6= 0 the Wald test
statistic is used.
2.4.2 Linear discriminant analysis
Another linear method for classiﬁcation is the linear discriminant analysis (see e.g. Hastie
et al. (2001)). Again a set of predictor variables X = (X1, X2, ..., Xm) is given. We
assume that the population can be split into l = 1, ..., K sub-populations (e.g. for 2
sub-populations: responder and non-responder). Assume that for a training sample the
corresponding true class R = k is known (e.g. 0 for non-responders and 1 for responders
in the case of 2 sub-populations). We are now searching for decision functions that
discriminates between two classes respectively. Therefore we need the class posteriors
P [R = k | X = x]. Let fk(x) be the class-conditional density of x in class R = k and
qk = P [R = k] the a priori probability of class k, where
∑K
k=1 qk = 1. From Bayes theorem
we get:
P [R = k | X = x] = fk(x)qk∑K
l=1 fl(x)ql
.
P [R = k | X = x] is the a posteriori probability that an observation (patient) with
predictor vector x belongs to class k. To estimate the a posteriori probability we have to
estimate fk(x) and qk from the sample.
Deﬁnition 2.4.2.1 Bayes decision rule: An observation with predictor vector x will
be allocated to the class which has the largest a posteriori probability P [R = k | X = x]:
kˆ such that P [R = kˆ | X = x] ≥ P [R = l | X = x] for l = 1, ...K
Deﬁnition 2.4.2.2 For a decision function kˆ = e(x) the conditional error rate is the
probability that an observation with true class k and predictors x is allocated to the wrong
class:
ε(e(x)) = P [e(x) 6= k | X = x].
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Deﬁnition 2.4.2.3 For a decision function kˆ = e(x) the total error rate is the probability
that an observation with predictors x is allocated to the wrong class:
ε(e) = P [e(x) 6= k].
Theorem 2.4.2.1 The Bayes rule minimizes the conditional error rate and thus also the
total error rate.
Linear discriminant analysis arises in the special case when we assume that the classes
have a common covariance matrix
∑
k =
∑ ∀k and each class density is multivariate
normal. When comparing 2 classes k and l we have to look at the log-ratio of the two a
posteriori probabilities and we see that:
log(
P [R = k | X = x]
P [R = l | X = x] ) = log(
fk(x)
fl(x)
) + log(
qk
ql
)
= log(
qk
ql
)− 1
2
(µk − µl)T
∑−1
(µk − µl) + xT
∑−1
(µk + µl)
an equation linear in x. The linear log-odds function implies that the decision boundary
between classes k and l, the set were P [R = k | X = x] = P [R = l | X = x], is linear in
x (in m dimensions a hyperplane).
Deﬁnition 2.4.2.4 Linear discriminant function:
LDF (x) = (µk − µl)T
∑−1
x− 1
2
(µk − µl)T
∑−1
(µk + µl)
Thus, one will decide for k if
(µk − µl)T
∑−1
x− 1
2
(µk − µl)T
∑−1
(µk + µl) > log(
qk
ql
)
and class l otherwise. In practice the parameters of the normal distribution are unknown
and we will have to estimate proportions, means and covariance matrices from the given
sample.
For a observed patient with predictor vector x we can now calculate K discriminant
functions. The patient will allocate to that class kˆ which has maximal LDFkˆ(x).
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2.5 The receiver operating characteristic curve
Various measures have been proposed to capture discrimination, but the receiver operating
characteristic curve (ROC-curve) has become the standard description of classiﬁcation
accuracy for scalar-used classiﬁers. It is a measure of the predictive ability of a score if the
score is used for diﬀerent thresholds with varying values of sensitivity and speciﬁcity. The
area under the ROC-curve (AUC) is the widely used measure to summarize the ROC. The
ROC-curve is currently the best-developed statistical tool for describing the performance
of tests with results that are not simply positive or negative but that are measured on
continuous scales. The following deﬁnitions, theorems and their corresponding proofs can
be found in Pepe (2003).
2.5.1 ROC-curve for continuous tests
Let R denote again the true response status, R = 1 if the patient is responding and R = 0
if he is not responding to a particular therapy.
Deﬁnition 2.5.1.1 Using a threshold c, a binary test from a continuous result from a
diagnostic test Y is deﬁned as positive if Y ≥ c and negative if Y < c. Let the the
corresponding true and false positive fractions at the threshold c be
TPF (c) = P [Y ≥ c | R = 1] and FPF (c) = P [Y < c | R = 0].
Note again that TPF and FPF are also known as sensitivity and 1-speciﬁcity.
Deﬁnition 2.5.1.2 The ROC curve is the entire set of possible true and false positive
fractions attainable by dichotomizing Y with diﬀerent thresholds. Thus the ROC-curve is
ROC(·) = {(FPF (c), TPF (c)), c ∈ (−∞,∞)}.
As the threshold c increases, both FPF (c) and TPF (c) decrease. At one extreme, c =∞,
we have limc→∞ TPF (c) = 0 and limc→∞ FPF (c) = 0. At the other extreme, c = −∞,
we have limc→−∞ TPF (c) = 1 and limc→−∞ FPF (c) = 1. Thus, the ROC-curve is a
monotone increasing function in the positive quadrant.
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Deﬁnition 2.5.1.3 Because of the above discussed properties, the ROC-curve can also
be written as
ROC(·) = {(t, ROC(t)), t ∈ (0, 1)},
where the ROC function maps t to TPF (c) and c is the threshold corresponding to
FPF (c) = t.
The ROC-curve is a monotone increasing function mapping (0, 1) onto (0, 1). An uninfor-
mative test is one such that Y is unrelated to the response status R. The probability dis-
tributions for Y are assumed to be the same in the responding and non-responding popula-
tions and therefore for any threshold c we have TPF (c) = FPF (c). The ROC-curve for a
useless test is therefore ROC(t) = t. A perfect test on the other hand completely separates
responding and non-responding subjects. Thus, for some threshold c, we have TPF (c) = 1
and FPF (c) = 0. Note that most tests have ROC-curves that lie between those of the
perfect and useless tests. Better tests have ROC-curves closer to the upper left corner.
If we choose thresholds cA and cB for which TPFA(cA) = TPFB(cB), the corresponding
false positive fractions are ordered in favor of test A, so that FPFA(cA) < FPFB(cB).
An important property of the ROC-curve is the following:
Theorem 2.5.1.1 The ROC-curve is invariant to strictly increasing transformations of
Y .
The ROC-curve for evaluating diagnostic tests provides a complete description of potential
performance, facilitates comparing and combining information across studies of the same
test, guides the choice of threshold in applications and provides a mechanism for relevant
comparisons between diﬀerent non-binary tests (see Pepe (2003)).
2.5.2 Area under the ROC-curve
The most widely used summary measure for the ROC-curve is the area under the ROC-
curve (AUC).
Deﬁnition 2.5.2.1 The area under the ROC-curve (AUC) is deﬁned as:∫ 1
0
ROC(t)dt
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A perfect test, one with the perfect ROC-curve, has the value AUC = 1, in contrast, an
uninformative test with ROC(t) = t has AUC = 0.5. Most tests have values falling in
between. Clearly, if two tests are ordered with test A uniformly better than test B, in the
sense that
ROCA(t) ≥ ROCB(t) ∀t ∈ (0, 1),
then their AUC statistics are also ordered
AUCA ≥ AUCB.
However, the converse is not necessarily true.
Let Yr denotes the test result for a (true) responding and Ynr for a (true) non-responding
patient respectively. The area under the ROC-curve can be interpreted as the probability
that in a randomly selected pair for responders and non-responders, the score value of the
non-responder is smaller than the score value of the responder:
Theorem 2.5.2.1 The following result holds:
AUC = P [Yr > Ynr]
where Yr and Ynr correspond to independent and randomly chosen test results from the
responding and non-responding populations, respectively.
This theorem has been shown by Bamber (1975). A proof of this theorem can also be
seen in e.g. Pepe (2003).
2.5.3 Binormal ROC-curve and AUC
To derive the functional form of the binormal ROC-curve, suppose that test results are
normally distributed in the responding and non-responding populations.
Theorem 2.5.3.1 If Yr ∼ N(µr, σ2r) and Ynr ∼ N(µnr, σ2nr) then
ROC(t) = Φ(a+ bz(t))
where a = (µr − µnr)/σr and b = σnr/σr and z(t) = Φ−1(t) denotes the t-quantile of the
standard normal distribution.
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Proof: For any threshold c,
FPF (c) = P [Ynr > c] = Φ(
µnr − c
σnr
),
TPF (c) = P [Yr > c] = Φ(
µr − c
σr
).
For a false positive fraction t, we see that c = µnr−σnrz(t) is the corresponding threshold
for the test positivity criterion. Hence,
ROC(t) = TPF (c) = Φ(
µr − c
σr
) = Φ(
µr − µnr + σnrz(t)
σr
) = Φ(a+ bz(t))
We call a the intercept and b the slope for the binormal ROC curve.
Theorem 2.5.3.2 The AUC for the binormal ROC curve is
AUC = Φ(
a√
1− b2 ).
Proof: Recall that AUC = P [Yr > Ynr] = P [Yr − Ynr > 0]. Let W = Yr − Ynr. Then
W ∼ N(µr − µnr, σ2r + σ2nr)
and
P [W > 0] = 1− Φ
−µr + µnr√
σ2r + σ
2
nr
 = Φ
−µr + µnr
σ2r
/
√√√√1 + σ2nr
σ2r
 = Φ( a√
1− b2
)
The AUC is an increasing function of a and a decreasing function of b.
2.5.4 Estimating the ROC-curve
We assume that the data can be represented as test results for nr cases and nnr controls:
Yr,i, i = 1, ..., nr and Ynr,i, i = 1, ..., nnr. We assume that Yr,i and Ynr,i are selected ran-
domly from the populations of test results associated with responding and non-responding
states, respectively. The empirical estimator of the ROC-curve simply applies the deﬁni-
tion of the ROC-curve to the observed data.
Deﬁnition 2.5.4.1 For each possible cut-point c, the empirical true and false positive
fractions are calculated as follows:
̂TPF (c) = nr∑
i=1
I[Yr,i ≥ c]/nr,
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̂FPF (c) = nnr∑
i=1
I[Ynr,i ≥ c]/nnr.
The empirical ROC curve, R̂OC(t), is a plot of ̂TPF (c) versus ̂FPF (c) for all c ∈
(−∞,∞).
Clearly the empirical AUC (ÂUC) can be calculated by applying there deﬁnition to the
empirical ROC. Note that the empirical R̂OC(t) is generally a step function.
A rank-based estimate of the AUC is the Mann-Whitney U Statistic introduced by Mann
and Whitney (1947). The following theorem was proven by Hanley and McNeil (1982).
Theorem 2.5.4.1 The area under the empirical ROC curve is the Mann-Whitney U-
statistic:
ÂUC =
nr∑
j=1
nnr∑
i=1
{
I[Yr,i > Ynr,i] +
1
2
I[Yr,i = Ynr,i]
}
/(nrnnr)
2.5.5 ROC-curve of a linear score
Let X = (X1, ..., Xm) again be a set of predictor variables. We now consider a linear
combination of the test result: S(β, X) =
∑m
i=1 βiXi.
Deﬁnition 2.5.5.1 The ROC-curve for a score S, is then deﬁned as the set of points
ROC(·) = {(FPF (c), TPF (c)), c ∈ (−∞,∞)}
where TPF (c) = P [Si > c | Ri = 1] which is interpreted as the true positive rate associated
with the positivity criterion S > c and FPF (c) = P [Si > c | Ri = 0] which is the false
positive rate at threshold c.
We now want to ﬁnd βopt which is the (β1, ..., βm) that maximizes the area under the
ROC-curve associated with S.
Theorem 2.5.5.1 If X1, ..., Xm has a multivariate normal distribution in each of the
responding (N [µr,Σ]) and non-responding populations (N [µnr,Σ]), then the score deﬁned
by the linear discriminant function maximizes the area under the ROC-curve:
βopt = (µr − µnr)TΣ−1
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This theorem was proven by Su and Liu (1993) (see also e.g. Pepe and Thompson (2002)).
It is well known that in the multivariate binormal setting the linear discriminant and
logistic scores are equal if the covariance matrices are proportional. The linear discrimi-
nant procedure has been shown to be statistically more eﬃcient when the model is correct.
Logistic regression, however, can be applied outside of the multivariate binormal setting.
It relies only on an assumption about the form of the conditional probability for response
given X1, ..., Xm and does not require speciﬁcation of the much more complex joint dis-
tribution of X1, ..., Xm. However, the logistic regression is not motivated as a procedure
which maximizes the area under the ROC-curve for a linear score. In logistic regression
analysis, the coeﬃcients are chosen to maximize the logistic likelihood. It is not clear
if the logistic likelihood relates to any natural measure of the discriminatory capacity of
the linear score. Hence, in general, the logistic regression linear score is not easily moti-
vated as an optimal discriminator of responding and non-responding populations except
in the multivariate binormal setting. It has been shown, however, that, if complete dis-
crimination is possible, the logistic regression will estimate the linear combination which
separates the populations (compare Pepe and Thompson (2002), Pepe et al. (2004)).
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3 Model selection for prediction of a
clinical outcome
3.1 Assumptions
We want to search for predictors of a binary outcome (e.g. success of a therapy) among a
large set of m candidate variables (e.g. genes, proteins). Independent samples of patients
responding (nr) and non-responding (nnr) to the therapy are available. Based on these
samples variables have to be selected and a score has to be constructed which will be used
to predict response to therapy in future patients. We will aim at a score which optimizes
the AUC.
To simplify the problem we ﬁrst assume that the variables follow normal distributions
with common known variance σ2 = 1 with means µr,i, i = 1, ...,m, for responders and
means µnr,i, i = 1, ...,m, for non-responders. Furthermore we assume that among the m
candidates there is a set E, me = ]{E}, of prognostic variables related to the clinical
outcome (alternatives). We also assume that these prognostic variables have a common
mean µr,i = µr, i ∈ E in the responding patients and also a common mean µnr,i = µnr,
i ∈ E in the non-responding patients. Hence a common eﬀect size µr−µnr = ∆ is assumed
for the prognostic variables. For the non-prognostic variables without loss of generality
the diﬀerence in means between responders and non-responders is assumed to be zero,
µr,j − µnr,j = 0, j ∈ (1, 2, ..,m) \ E (true null hypotheses).
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3.2 Selection of variables for future prediction
We investigate two methods for the selection of promising variables to build a prediction
score for a clinical outcome of a future patient.
3.2.1 Selection based on a multiple test controlling the FDR
For the selection of variables for the prediction score we test the following set of one-sided
null hypotheses:
H0i : µr,i − µnr,i = 0 against H1i : µr,i − µnr,i > 0 for i = 1, . . . ,m.
The standardized mean diﬀerences between responder and non-responder
zi = (x¯r,i − x¯nr,i)
√
n/2, i = 1, . . . ,m
are calculated, where for simplicity we assume equal sample sizes per variable and group
n = nr,i = nnr,i for i = 1, . . . ,m. The test decisions are based on the one-sided p-values
pi = 1− Φ(zi),
where Φ denotes the cumulative distribution function of the standard normal distribution
(see theorem 2.1.0.3). Note that the two-sided case is considered later.
To adjust for multiplicity, i.e. not to include too many nuisance variables without any
predictive ability in the score, we use Storeys approach (Storey (2002)) to control the
FDR (see Section 2.3.2). Due to formula (2.6) the critical boundary is determined from
the sample such that the estimated FDR never exceeds the targeted value α. Note that
this method adapts to the estimated proportion of true null hypotheses.
The variables whose p-values fall below the critical boundary γ (pi < γ) correspond-
ing to the targeted threshold α are selected to build a score in order to predict whether
a future patient will respond or not respond to the treatment.
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3.2.2 Selection based on stepwise forward logistic regression
Whereas the ﬁrst approach is only based on individual selection criteria for the variables,
here we use a multiple logistic regression approach (see Section 2.4.1) with stepwise for-
ward selection to assess the contribution of the individual variables to predict response
to therapy in the training sample. We again use a ﬁxed threshold γ for the p-values, this
time calculated from the ﬁnal model evolving in the multivariate logistic regression. The
selection is done in such a way that selected variables can again be removed from the
model when their p-values in the aggregated model fall above the threshold γ. The step-
wise procedure ends with a ﬁnal model when further variables fail to meet the selection
criterion.
3.3 Prediction of the clinical outcome
Based on our assumptions we simply use the linear score of the selected variables. This
would be the optimal solution in the case of no selection for a given set of variables which
follow independent and identical normal distributions with unknown means and known
variance σ2 = 1 (as in the classical linear discriminant analysis, see theorem 2.5.5.1).
Thus in our case we use the following prediction score:
Deﬁnition 3.3.0.1 Let x¯r,i and x¯nr,i denote the sample means of the ith variable of pa-
tients responding and not responding to therapy respectively and x = (x1, ..., xm) the values
of the variables of a future patient. The prediction score is a linear combination of x:
fˆ(x; γ) = cˆTx =
m∑
i=1
cˆixi. (3.1)
where
cˆi =
{
x¯r,i − x¯nr,i if pi < γ
0 else
. (3.2)
I.e. k ≤ m variables for which pi < γ are selected to build a linear score and m − k
variables are not selected (their weights in the score are set to 0).
If fˆ(x; γ) > b we predict a response, otherwise a non-response. To measure the pre-
dictive ability of such a score we use the ROC-curve resulting from varying threshold
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values for the score, where sensitivity (TPF), further denoted by v, is plotted against
FPF=(1-speciﬁcity), further denoted by w, as a function of b (see Section 2.5). Since we
are interested in ROC-curves the following results are invariant to any strictly monotonic
transformation of this score (see theorem 2.5.1.1).
In case of forward selection we simply use the estimated linear predictor for the log
odds from the ﬁnal model in the forward logistic regression, which is of the same form as
(3.1) but uses the parameter estimates (βi) from the model instead of the diﬀerence in
the sample means of the selected variables.
Theorem 3.3.0.1 Given the selection threshold α for the FDR (and thus the correspond-
ing selection boundary γ for the individual p-values) and the estimated weights (3.2) from
the samples the prognostic score (3.1) follows two normal distributions:
fˆ(x; γ) ∼ N [µa, σ2a] = N [cˆTµa, cˆT cˆ]
where µa, a = r or nr is the true mean vector in a future responder or non-responder,
respectively. Note that because of the independence between variables the true covariance
matrix Σ = I.
Proof: This result can be simply calculated using theorem 2.1.0.7 in Section 2.1.
Theorem 3.3.0.2 Fixing the appropriate µa for the populations of responders and non-
responders, respectively, the AUC for future independent populations can be calculated
as:
AUC(α) =
∫ 1
0
{
1− Φ
[
z(1− w)− cˆ
T (µr − µnr)√
cˆT cˆ
]}
dw (3.3)
where z(q) is the q-quantile of the standard normal distribution.
Proof: This can be calculated from:
Sensitivity = v = 1− ΦcˆTµr,cˆT cˆ(b) = 1− Φ(
b− cˆTµr√
cˆT cˆ
) (3.4)
and
Specificity = 1− w = ΦcˆTµnr,cˆT cˆ(b) = Φ(
b− cˆTµnr√
cˆT cˆ
) (3.5)
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where Φµ,σ2 denotes the cumulative distribution function of the normal distribution with
mean value µ and variance σ2. Calculating b from formula (3.5) results in:
b = z(1− w)
√
cˆT cˆ + cˆTµnr.
Inserting this into formula (3.4) results in (3.3).
For the prognostic score based on the logistic regression similar results can be derived.
3.4 Assumptions on the effect size ∆
To get a benchmark let us assume that the optimal linear score built from the me prog-
nostic variables is known. We now will ask, depending on the number me of prognostic
variables, what minimal common eﬀect size ∆ is required to achieve a ROC-curve cross-
ing through the point where both sensitivity (v) and speciﬁcity (1 − w) have a certain
pre-speciﬁed values?
Theorem 3.4.0.3 Under the assumption of equal eﬀect sizes among the alternatives, the
eﬀect size required for a ROC-curve crossing through the ﬁxed point (v, 1 − w) can be
calculated as:
∆ =
z(1− w)− z(1− v)√
me
(3.6)
Proof: Clearly we get the best prognostic score if all me prognostic variables and no
non-prognostic variables are selected, i.e. we know the true score:
f(x) = Σi∈Exi.
Note that for equal eﬀect sizes ∆ for the alternatives, the constant true weights (∆) can
be ignored in the score. From theorem 2.1.0.7 we know that this score follows a normal
distribution:
f(x) ∼ N [µf , σ2f ] = N [me∆,me]
Hence the sensitivity for the theoretically best score for a future patient can be easily
calculated as follows:
v = 1− Φ(z(1− w)− me∆√
me
) = 1− Φ(z(1− w)−√me∆).
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Figure 3.1: Minimal eﬀect size ∆ required to achieve a ROC-curve crossing through the point where
sensitivity and speciﬁcity are equal to 0.9 as a function of the number of prognostic variables
me. (Figure from Goll (2008)).
By solving the equation it turns out that the eﬀect size required to cross the point (v, 1−w)
can be calculated as in formula (3.6).
In the following we choose v = 1 − w = 0.9, i.e. a theoretically best achievable AUC of
AUC∗ = 0.965 can be achieved. Figure 3.1 (Figure from Goll (2008)) shows the minimal
eﬀect size ∆ depending on the number of prognostic variables related with the clinical
outcome (me) if the best ROC-curve is assumed to cross the point where v = 1−w = 0.9.
Two examples are marked which will be considered more closely in the simulation studies.
For me = 60 an eﬀect size of ∆ = 0.331 is required to achieve such an ROC-curve. For
me = 10 an eﬀect size of ∆ = 0.811 is needed to get a ROC-curve with such a property.
Note that if there is only a single prognostic variable an eﬀect size of ∆ = 2.563 is required.
This demonstrates the crucial problem for gene expression or proteomic studies. If many
prognostic variables work together they may show a large common eﬀect even if there are
only marginal individual eﬀect sizes. Thus, the process of selection of such variables with
only marginal eﬀects among a large number of candidates in relatively small samples will
be a formidable task. However, in case of a single or few prognostic variables the eﬀect
size to achieve good prognostic properties has to be pretty large, so that already small
samples may be suﬃcient to select those very inﬂuential variables.
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3.5 Variable selection using the FDR approach:
simulation studies
Similar results of the simulation studies can also be seen in my doctorial thesis (see Goll
(2008)). However, for this thesis we use a more sophisticated optimization procedure to
determine the optimal selection threshold. Thus, there may be slight diﬀerences of the
following results as compared to Goll (2008).
We investigate the selection procedure using a multiple test for constructing a linear score
discussed in Section 3.3 by simulation, assuming that two samples of patients responding
to a particular treatment and of patients not responding to the treatment are available.
For a ﬁxed FDR threshold α we can now calculate in a speciﬁc sample AUC(α) using
formula (3.3). For a grid of α values with interval 0.01 AUC(α) is evaluated by simulation
(10000 simulation runs). The optimal FDR level αopt to achieve the best prediction with
a linear score in terms of the AUC(α) in a speciﬁc scenario is hard to determine analyt-
ically in ﬁnite samples. It has to be kept in mind that AUC(α) is a random variable.
Thus, optimization of α is based on the averages of the simulated AUC(α) values. For
the simulated mean values of AUC(α) for the grid of α values we interpolate a function
using splines. To determine αopt which optimizes the average AUC(α), we optimize this
interpolated function. Note again that this optimization procedure is a further investi-
gation of the results in Goll (2008) where only a grid with interval 0.05 was investigated
and no interpolation was done.
Diﬀerent parameter constellations are investigated: we vary the number of prognostic
variables related with the clinical outcome to be me = 10 or 60. We ﬁx the group sample
sizes to nr = nnr = 50, 100 and 500 and the number of candidate variables to m = 1000
and 6000. We also investigate the situation under the global null hypothesis (me = 0). As
discussed in Section 3.4, the eﬀect size ∆ is triggered by forcing the optimal ROC-curve
through the benchmark point v = 1 − w = 0.9, thus for me = 10, ∆ = 0.811 and for
me = 60, ∆ = 0.331.
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3.5.1 Searching among m=1000 hypotheses
Figure 3.2 shows the interpolated functions of mean values of AUC(α) over the simulated
samples (10000 simulation runs) as a function of α chosen a priori for the selection of vari-
ables for future prediction assuming a sample size of n = 50 (dotted line), 100 (dashed
line) and 500 (dotdashed line) per group. me = 10 prognostic variables are searched
within m = 1000 candidate genes. Note that if no score is selected in a speciﬁc sample
AUC(α) is set to 0.5. The best achievable AUC∗ = 0.965 is shown as solid horizontal line.
The ﬁgure shows that if a larger α is chosen, more non-prognostic variables are toler-
ated in the score but also more prognostic variables are selected so that the score still
performs well. However, if a too large α is chosen for selection, too many non-prognostic
variables are added so that the score gets worse if small sample sizes are applied. When
increasing the sample size per group clearly the mean values of AUC(α) of the selected
scores also increase. It can be seen that the resulting scores perform well for a wide range
of α values for larger sample sizes. This may be due to the better estimate of µr,i and
µnr,i for i = 1, ...,m and thus to a better estimate of the weights in the score function
when the sample size increases. It seems that for n = 500 it does not really mind which
FDR threshold is chosen as selection criteria, the resulting score always performs good.
The weights of selected true null hypotheses are nearly null, although their p-values are
signiﬁcant for larger FDR levels. See a detailed summary of the results in Table 3.1. For
ﬁxed m from simple consistency arguments it follows:
Theorem 3.5.1.1 Given any positive α for the selection threshold:
lim
n→∞ cˆi = ∆ ∀i ∈ E and
lim
n→∞ cˆj = 0 ∀j ∈ (1, ...,m)\E
if the selected model is too large and contains non-prognostic variables. Therefore
lim
n→∞AUC(α) = AUC∗ ∀α.
If we assume me = 60 alternatives among the m = 1000 tested candidate variables, the
eﬀect size ∆ to achieve the theoretical benchmark ROC-curve now is 0.331. Figure 3.3
36
3.5 Variable selection using the FDR approach: simulation studies
again shows the interpolated functions of the mean values (over the simulated samples) of
AUC(α) varying the FDR threshold α. Again it is better to tolerate more non-prognostic
variables and thus ﬁnd more prognostic ones, however for small sample sizes (see e.g. the
dotted line for n = 50) it would be superior to choose an unrealistically large αopt. Again
increasing the sample size per group clearly also increases the AUC(α) values of the se-
lected scores. A good performance in terms of future AUC values can be seen over all
investigated FDR thresholds α if the sample size is increased to n = 500. See a detailed
summary of the results in Table 3.1.
Over all investigated examples αopt is decreasing and AUC(αopt) is increasing with in-
creasing n. αopt is increasing and AUC(αopt) is decreasing with increasing me .
Figure 3.2: Interpolated functions of mean values of AUC(α) over the simulated samples (10000 sim-
ulation runs) for a varying FDR threshold α for selection assuming me = 10 prognostic
variables among m = 1000 tested variables. The sample size per group is set to n = 50
(dotted line), 100 (dashed line) and 500 (dotdashed line). AUC∗ = 0.965 is given as solid
horizontal line. The eﬀect size ∆ = 0.811.
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Figure 3.3: Interpolated functions of mean values of AUC(α) over the simulated samples (10000 sim-
ulation runs) for a varying FDR threshold α for selection assuming me = 60 prognostic
variables among m = 1000 tested variables. The sample size per group is set to n = 50
(dotted line), 100 (dashed line) and 500 (dotdashed line). AUC∗ = 0.965 is given as solid
horizontal line. The eﬀect size ∆ = 0.331.
3.5.2 Searching among m=6000 hypotheses
Let us furthermore have a look at the situation assuming me = 10 and me = 60 prog-
nostic variables (alternatives) among m = 6000 tested hypotheses. Because of the larger
number of candidate variables the problem to ﬁnd the alternatives becomes harder. The
eﬀect size ∆ remains the same, thus ∆ = 0.811 for me = 10 since it only depends on
the number me of alternatives and not on the number of tested hypotheses. Figure 3.4
shows the situation assuming me = 10 ﬁxing the sample size per group to n = 50 (dotted
line), 100 (dashed line) and 500 (dotdashed line). Clearly the AUC(α) values are smaller
as compared to the scenario with m only equal to 1000. However, for n = 50, due to
the large eﬀect size, selection may lead to good prediction scores if the right threshold is
chosen for selection, although selecting out of 6000 hypotheses. Increasing the sample size
to n = 100 per group again increases AUC(αopt) and decreases αopt. A further increase
of the sample size per group to n = 500 results, as in the case of m = 1000, in a good
performance for a wide range of α values. For small values of α, AUC(αopt) for future
prediction is almost equal to AUC∗ = 0.965. For larger α values the performance is only
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slightly smaller.
Assuming me = 60 among m = 6000 hypotheses, the situation gets worse. Because
of the small eﬀect size (∆ = 0.331) and the larger number of hypotheses to test no good
prediction score can be selected if the sample size per group is small. Figure 3.5 shows
the results. Applying a sample size of n = 50 the best choice of the selection threshold
would be an unrealistically large αopt, which applied as selection criterion would lead to
prediction scores achieving only an average AUC(αopt) smaller than 0.7. This indicates
a poor performance of the resulting scores as compared to AUC∗ = 0.965. This again
describes the problem of such studies. If only a few prognostic variables with a large eﬀect
size exist it may be possible to ﬁnd good prediction scores if the right selection criterium is
used, but if there are many variables with low eﬀect sizes working together, searching for
prediction scores with rather small sample sizes becomes a formidable problem. Increas-
ing the sample size to n = 100 per group the situation improves a little as compared to
n = 50. A further increase of the sample size per group to n = 500 changes the situation
completely. Again, for a wide range of α values the future performance remains good (see
Table 3.1).
A detailed summary of the results can be seen in Table 3.1. For m = 6000 the same
tendencies can be seen as for m = 1000. Over all investigated examples αopt is decreas-
ing and AUC(αopt) is increasing with increasing n. αopt is increasing and AUC(αopt) is
decreasing with increasing me. For increasing m, αopt is increasing and AUC(αopt) is
decreasing.
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Figure 3.4: Interpolated functions of mean values of AUC(α) over the simulated samples (10000 sim-
ulation runs) for a varying FDR threshold α for selection assuming me = 10 prognostic
variables among m = 6000 tested variables. The sample size per group is set to n = 50
(dotted line), 100 (dashed line) and 500 (dotdashed line). AUC∗ = 0.965 is given as solid
horizontal line. The eﬀect size ∆ = 0.811.
Figure 3.5: Interpolated functions of mean values of AUC(α) over the simulated samples (10000 sim-
ulation runs) for a varying FDR threshold α for selection assuming me = 60 prognostic
variables among m = 6000 tested variables. The sample size per group is set to n = 50
(dotted line), 100 (dashed line) and 500 (dotdashed line). AUC∗ = 0.965 is given as solid
horizontal line. The eﬀect size ∆ = 0.331.
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Table 3.1: Simulation results for selection using the FDR approach: The best
choice of the FDR threshold (αopt), the corresponding AUC(αopt) as well as the number
of selected non-prognostic variables (ms0) and the number of selected prognostic variables
(mse) for varying number of prognostic variables (me), tested hypotheses (m) and per group
sample sizes (n). Note that AUC∗ = 0.965.
m me ∆ n αopt AUC(αopt) m
s
0 m
s
e
1000 10 0.811 50 0.170 0.941 1.92 8.69
0.811 100 0.014 0.963 0.14 9.90
0.811 500 0.001 0.965 0.01 10.00
60 0.331 50 0.824 0.813 254.02 48.98
0.331 100 0.475 0.888 40.86 43.66
0.331 500 0.033 0.961 2.04 59.53
6000 10 0.811 50 0.250 0.917 2.81 7.59
0.811 100 0.034 0.960 0.36 9.70
0.811 500 0.001 0.965 0.11 10.00
60 0.331 50 0.895 0.669 323.04 27.81
0.331 100 0.611 0.792 46.07 27.31
0.331 500 0.034 0.959 0.83 57.50
3.5.3 Variable Selection expecting a small AUC∗
In the last examples we assumed that the optimal linear prediction score of future pa-
tients, if known, would lead to a ROC-curve crossing through the benchmark point where
sensitivity and speciﬁcity are 0.9, which corresponds to a theoretically achievable AUC∗
of 0.965 indicating a (in truth) very good discrimination between responders and non-
responders. However in medical research often there is no such a good discrimination
between two groups. Thus, in the following we will investigate scenarios, where AUC∗ is
assumed to be 0.8, which may be more realistic in medical research. To achieve a future
performance of AUC∗ = 0.8 the benchmark point is at v = 1 − w = 0.724 (assuming
a ROC-curve crossing through a point, where sensitivity and speciﬁcity are the same).
The minimal ∆ required to obtain this ROC is 0.376 assuming me = 10 alternatives and
0.154 for me = 60. Figure 3.6 (Figure from Goll (2008)) shows the minimal required
∆ for diﬀerent values for AUC∗. Results assuming 10 (dashed line) and 60 (solid line)
prognostic variables are shown. The results for assuming a theoretically achievable AUC∗
of 0.8 and 0.965 (as assumed in the previous sections) are marked.
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Figure 3.6: Minimal required eﬀect size ∆ as a function of the theoretically best possibleAUC∗ assuming
the number of prognostic variables me = 10 (dashed line) and 60 (solid line) (Figure from
Goll (2008)).
We again performed simulations (10000 simulation runs) assuming me = 10 and 60 al-
ternatives among m = 1000 and 6000 hypotheses for a grid of α values with interval
0.01. The optimization of αopt is again based on the interpolated functions from the mean
values of the simulated AUC(α) values for each point of the γ-grid. The sample size per
group is set to n = 50, 100 and 500.
Figure 3.7 shows the resulting mean AUC(α) values assuming me = 10 among 1000
hypotheses. Applying a small sample size per group we will not be able to ﬁnd good pre-
diction scores whatever FDR threshold α is used for selection. The mean AUC(α) values
for future prediction are smaller than 0.6 over the whole range of α values. Larger sample
sizes are needed to detect the alternatives with their only small eﬀect sizes required to
achieve AUC∗ = 0.8. However, when doubling the sample size to n = 100 per group only
a small increase in values of AUC(αopt) can be seen. Fixing the sample size to n = 500
leads to good prediction scores for small αopt values.
Increasing the number of prognostic variables to me = 60 hypotheses (Figure 3.8) again
a very large sample size is needed to achieve good prediction scores. However, ﬁxing the
sample size to n = 500 per group on average AUC(αopt) is only 0.720. For n = 50 the
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AUC values do not exceed 0.6 over the whole range of investigated α values. The results
of the simulated examples are summarized in Table 3.2.
If the prognostic variables are searched among 6000 hypotheses the situation gets ex-
tremely worse if smaller sample sizes are considered (Figures 3.9 and 3.10). Increasing
the sample size to n = 500 per group helps if only a small number of alternatives with
large eﬀect sizes is assumed. Whereas for me = 10 (Figure 3.9) large AUC(αopt) values
can be obtained for small αopt values, for me = 60 (Figure 3.10), the average AUC(αopt)
does not exceed 0.7. Thus the conclusion is that if there is only a moderate true discrimi-
nation between responders and non-responders very large sample sizes are required to get
good prediction scores. Studies with small sizes will mostly produce useless prediction
scores (see the summary in Table 3.2).
The following result can be determined:
Theorem 3.5.3.1 Let ∆1 be the required eﬀect size to achieve AUC∗,1 and ∆2 the required
eﬀect size to achieve AUC∗,2. The per-group sample size n2 to achieve the same selection
procedure as from the other sample (with per-group sample size n1) can be calculated by:
n2 =
(
∆1
∆2
)2
n1.
Proof: Given m and me, scenarios with the same value of ∆
√
n lead to identical selection
procedures, i.e. to the same test-statistics and thus to the same selected prognostic and
non-prognostic variables. Thus to get the same test statistic:
∆1
√
n1/2 = ∆2
√
n2/2.
By solving the equation it can easily be calculated that n2 =
(
∆1
∆2
)2
n1.
For example, to get the same selection procedure in the situation of AUC∗ = 0.8, we need a
(0.81/0.38)2 ≈ 4.6 times larger sample size as compared to the situation of AUC∗ = 0.965.
However, because of the smaller eﬀect sizes the AUC achieved in this case may be rela-
tively smaller. E.g. for α = 0.17 and applying a sample size of n = 232 we get an average
AUC(α) of 0.767 (95.9% of AUC∗ = 0.8) as compared to 0.941 (97.5% of AUC∗ = 0.965)
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for n = 50. For α = 0.6 the numbers are 0.741 (92.6% of AUC∗ = 0.8) versus 0.916
(94.9% of AUC∗ = 0.965).
Figure 3.7: Interpolated functions of mean values of AUC(α) over the simulated samples (10000 sim-
ulation runs) for a varying FDR threshold α for selection assuming me = 10 prognostic
variables among m = 1000 tested variables. The sample size per group is set to n = 50
(dotted line), 100 (dashed line) and 500 (dotdashed line). AUC∗ = 0.8 is given as solid
horizontal line. The eﬀect size ∆ = 0.376.
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Figure 3.8: Interpolated functions of mean values of AUC(α) over the simulated samples (10000 sim-
ulation runs) for a varying FDR threshold α for selection assuming me = 60 prognostic
variables among m = 1000 tested variables. The sample size per group is set to n = 50
(dotted line), 100 (dashed line) and 500 (dotdashed line). AUC∗ = 0.8 is given as solid
horizontal line. The eﬀect size ∆ = 0.154.
Figure 3.9: Interpolated functions of mean values of AUC(α) over the simulated samples (10000 sim-
ulation runs) for a varying FDR threshold α for selection assuming me = 10 prognostic
variables among m = 6000 tested variables. The sample size per group is set to n = 50
(dotted line), 100 (dashed line) and 500 (dotdashed line). AUC∗ = 0.8 is given as solid
horizontal line. The eﬀect size ∆ = 0.376.
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Figure 3.10: Interpolated functions of mean values of AUC(α) over the simulated samples (10000 sim-
ulation runs) for a varying FDR threshold α for selection assuming me = 60 prognostic
variables among m = 6000 tested variables. The sample size per group is set to n = 50
(dotted line), 100 (dashed line) and 500 (dotdashed line). AUC∗ = 0.8 is given as solid
horizontal line. The eﬀect size ∆ = 0.154.
Table 3.2: Simulation results for selection using the FDR approach assuming
a smaller AUC∗: The best choice of the FDR threshold (αopt), the corresponding
AUC(αopt) as well as the number of the selected non-prognostic variables (ms0) and the
number of selected prognostic variables (mse) for varying number of prognostic variables
(me), tested hypotheses (m) and per group sample sizes (n). AUC∗ = 0.8.
m me ∆ n αopt AUC(αopt) m
s
0 m
s
e
1000 10 0.376 50 0.794 0.595 36.47 4.61
0.376 100 0.493 0.675 7.03 5.50
0.376 500 0.014 0.796 0.15 9.97
60 0.154 50 0.919 0.582 405.62 37.75
0.154 100 0.893 0.613 373.63 42.99
0.154 500 0.442 0.720 36.13 44.27
6000 10 0.376 50 0.875 0.544 69.29 2.86
0.376 100 0.594 0.612 8.25 3.45
0.376 500 0.034 0.793 0.35 9.82
60 0.154 50 0.981 0.532 2522.14 34.09
0.154 100 0.972 0.547 2055.65 36.87
0.154 500 0.561 0.657 37.68 27.87
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3.6 Variable selection using forward logistic regression
For a comparison also forward logistic regression has been investigated as a method of
variable selection. Again ∆ was set to 0.811 in the case of me = 10 and to 0.331 for
me = 60. Because of run-time problems and problems with memory capacity when test-
ing a very large number of hypotheses m, simulations (1000 simulation steps) were only
performed for m = 1000. Diﬀerent thresholds γ are applied for the individual p-values in
the stepwise selection based on the multiple logistic regression. The simulations for the
logistic regression were done using the SAS 9.1. system.
The simulation results of the forward logistic regression show that this selection method
for the investigated scenarios performs poor in terms of AUC values for prediction of
the outcome of future patients as compared to the selection procedure using the FDR
approach. The poor result may be due to the following reason: in a small training sample
the forward logistic regression generally leads to a complete separation of data points, i.e.
responders and non-responders of the validation data set can be fully separated with the
found regression model. Only a few prognostic variables are selected for future prediction
using the forward logistic regression which leads to the worse performances of the predic-
tion scores.
For the independent case, the best performance for the situation of me = 10 occurs
for γopt = 0.0005 with AUC(γopt) = 0.812 for n = 50 and again at γopt = 0.0005 with
AUC(γopt) = 0.900 for n = 100. The forward logistic regression applying a larger sample
size clearly performs better. However, AUC(γopt) for the selection procedure using the
FDR was 0.941 for n = 50 and 0.961 for n = 100. Note that for n = 50 in average only
2.881 and for n = 100 only 5.644 out of the 10 alternatives are selected using the logistic
regression.
In the case of me = 60 for γ = 0.0073 up to 0.05 the mean AUC(γ) on average is 0.613
for n = 50. Because of complete separation almost the same performance is achieved for
γ ≥ 0.0073. Setting n = 100 per group a similar result can be seen. Again choosing
γ ≥ 0.0073 lead to the same performance achieving an average AUC(γ) = 0.696. Note
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that AUC(αopt) for selection using the FDR was 0.813 for n = 50 and 0.888 for n = 100
per group. However, the theoretically achievable AUC∗ is 0.965, which is not achieved
with both selection methods.
Note that if we assume correlation between hypotheses, the forward logistic regression
model also results in complete separation after selecting a few variables. Furthermore
considering a large positive autoregressive correlation structure between alternatives and
the neighboring true null hypotheses (as considered later) leads to numerical problems
and the model results in implausible estimates for the selected variables. This may also
be due to the fact that the underlying data is not generated based on a logistic regres-
sion model. Due to the mentioned reasons the logistic regression is no good procedure to
determine a prediction score for the given data structure and will not be considered in
further applications.
3.7 Situation under the global null hypothesis
Under the global null hypothesis of no existing prognostic variable at all (me = 0) the
ROC curve is always the diagonal (AUC= 0.5). Whatever selection procedure is used,
if variables are selected, they are always non-prognostic variables (true null hypotheses)
and thus the prediction score is useless. For selection using a multiple test controlling the
FDR, by deﬁnition, the probability to end with a selection of variables and building a
score is targeted at the pre-chosen FDR threshold α. Hence in the case of the global null
hypothesis it would have been better to choose a small FDR. However, if a large number
of alternatives are expected with rather small eﬀect sizes a very large FDR should be
chosen as selection criterion.
If we select variables using the forward logistic regression, we may have problems to
evaluate the level of false discoveries. However, as for the FDR selection method, the
results depend on the boundary γ chosen a priori. E.g. if we decided for Bonferroni
corrected boundaries (γ = 0.00005) in only 2.9% of the 1000 simulated cases at least one
variable was identiﬁed for future prediction but when increasing γ to 0.0025 in 98.3%
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useless prediction scores are produced.
This again demonstrates the dilemma of the task we are faced with. It may be pos-
sible to improve the selection and estimation procedures but a contradiction will remain:
being cautious may help not to produce too many nuisance results if the postulated re-
lationships do not exist. Being more optimistic and liberal may improve the results if in
fact variables related with the clinical outcome exist, but under the global null useless
scores may be produced.
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4 A cross validation method to
estimate an appropriate selection
criterion
We have seen from the previous sections that under the given assumptions the forward
logistic regression may not be a good selection procedure if small sample sizes are given.
There are problems to quantify the number of false positives in a score built with the
logistic regression model. Furthermore, there may be numerical problems in the calcula-
tions of the estimates. The simple method using a multiple test controlling the FDR and
just building a weighted sum of the selected hypotheses (as in the classical discriminant
analysis) leads, if the right selection threshold is chosen, to a better performance in terms
of AUC values for prediction of the outcome of a future patient. However, it remains
the question, how to choose the "optimal" selection boundary, because depending on
the parameter constellation (varying number of tested hypotheses, varying proportion of
prognostic variables and varying sample size), diﬀerent boundaries are required in order
to achieve a large AUC for future independent patients.
4.1 The cross validation procedure
To estimate an appropriate selection threshold αˆopt for selection using a multiple test
controlling the FDR, we investigated in Goll (2008) and Goll and Bauer (2008) a cross
validation procedure. Note that therefore we again ﬁrst assume that the variable levels
follow independent normal distributions with mean vector µr for responder and µnr for
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non-responder and known variance σ2 = 1. Deviations from these simple assumptions are
considered later.
For this cross validation procedure we decided to search for the optimal γˆopt for the
individual p-values instead of αˆopt because of the extremely longer runtime needed to
search for the corresponding γ values in each training set. For the ﬁnal selection bound-
ary γˆopt the corresponding FDR threshold αˆopt can be estimated with Storey's estimator
(see Section 2.3.2) in the total sample. Storey et al. (2004) showed that searching for the
optimal FDR and γ asymptotically leads to the same. However, despite the long runtime,
for some scenarios we performed simulations of the procedure searching for αˆopt. The
results were very similar (data not shown).
The cross validation procedure works as follows:
From a given data set with nr responders and nnr non-responders, a pair of a single
responder and a single non-responder respectively is left out. Note that there are nrnnr
possibilities (= n2 if nr = nnr = n as assumed in the previous sections) for leaving out
a pair of one responder and one non-responder. The remaining (nr + nnr − 2) patients
(nr − 1 responder and nnr − 1 non-responder) in each of the nrnnr "training" samples
respectively are used to estimate prediction scores applying a grid of values γ for the
selection boundary. As discussed in Section 3.2, the variables, whose one sided p-values
lie below the selection boundary γ are selected to build a score for future prediction. For
the left out responder and non-responder respectively we now calculate for each γ, the
value of the corresponding prediction score:
fˆ(ij)(xr,i; γ) = cˆ(ij)(γ)
Txr,i and fˆ(ij)(xnr,j; γ) = cˆ(ij)(γ)Txnr,j
where cˆ(ij)(γ) is the vector of the weights of the score calculated from the training sample
leaving out the ith responder and the jth non-responder, using γ as selection boundary.
xr,i and xnr,j denote the corresponding values of the (selected) variables of the single
responder and non-responder respectively left out in the construction of the score. Now
for each investigated γ the following cross validation function CFij is calculated.
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Deﬁnition 4.1.0.1 For a given selection threshold γ, the cross validation function is
calculated by:
CFij(xr,i,xnr,j; γ) =

0 if fˆ(ij)(xr,i; γ) < fˆ(ij)(xnr,j; γ)
1 if fˆ(ij)(xr,i; γ) > fˆ(ij)(xnr,j; γ)
0.5 if fˆ(ij)(xr,i; γ) = fˆ(ij)(xnr,j; γ)
. (4.1)
If no prediction score is selected from the data using the given γ, CFij(xr,i,xnr,j; γ) = 0.5.
The values of CFij(xr,i,xnr,j; γ) for each γ are now calculated for all nrnnr training sam-
ples. Note that in our balanced scenario overall we use nrnnr pairs of a single responder
and non-responder as validation sample. For each γ we can calculate a "cross validation
based" area under the ROC-curve.
Deﬁnition 4.1.0.2 For a given γ, the cross validation based ÂUC(γ) is calculated by:
ÂUC(γ) =
1
nrnnr
nr∑
i=1
nnr∑
j=1
CFij(xr,i,xnr,j; γ). (4.2)
It can be shown that the Mann-Whitney-U statistic (4.2) is the AUC of the empirical
ROC-curve in the independent sample case (see theorem 2.5.4.1 and e.g. Hanley and
McNeil (1982), Pepe (2003), Pepe et al. (2006)). Finally we choose the selection boundary
γˆopt such that it maximizes ÂUC(γ).
Deﬁnition 4.1.0.3 The best choice of the selection boundary, γˆopt, is calculated by:
γˆopt = arg max
γ
 nr∑
i=1
nnr∑
j=1
CFij(xr,i,xnr,j; γ)
 (4.3)
This is a special case of the maximum rank correlation estimator known to be consis-
tent and asymptotically normal when used for the parameters of a the generalized linear
model with a given set of predictors (see Han (1987), Sherman (1993), Pepe et al. (2006)).
As already mentioned before the corresponding FDR threshold αˆopt is calculated as fol-
lows:
Deﬁnition 4.1.0.4 The best choice of the threshold α for the FDR, αˆopt, can be calculated
as function of γˆopt using Storey's estimator:
αˆopt(γˆopt) =
]{pi>λ}
(1−λ) γˆopt
max(]{pi < γˆopt}, 1)
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where pi, i = 1, ...,m are the p-values from the individual z-tests calculated from the
total sample of nr responder and nnr non-responder and λ is a constant chosen a priori
(compare Section 2.3.2). αˆopt(γˆopt) is further on only denoted by αˆopt.
Note that in the following λ is set to 0.5 as in Storey (2002) (compare Section 2.3.2).
Below we will investigate by simulation how this estimator of the best FDR threshold
α behaves for increasing sample sizes when the set of predictors is chosen from model
selection. Generally a large number of weights in the score is set to zero by selection
based on an α which is chosen in a data driven way by optimizing ÂUC(γ).
Note also that if more than one γ fulﬁlls the cross validation criterion (4.3), the min-
imum of these γ values is chosen as ﬁnal selection boundary.
Since we are working with simulations we can also calculate the asymptotic FDR:
Deﬁnition 4.1.0.5 Assuming that pi0 and ∆ are known the best choice of the FDR thresh-
old can be calculated directly from γˆopt by:
αˆopt,∞(γˆopt,∆, pi0) =
pi0γˆopt
pi0γˆopt + (1− pi0)(1− β(γˆopt))
where (1 − β(γˆopt)) = 1 − Φ√n
2
∆,1
(c1−γˆopt) is the power of the performed one-sided two-
sample z-tests (compare Section 2.3.2). αˆopt,∞(γˆopt,∆, pi0) is further on only denoted by
αˆopt,∞.
It may be also interesting to look at the FWER, which is calculated numerically in the
simulations below which turns out to be close to the value (1− (1− γˆopt)mpi0) ignoring the
random nature of γˆopt.
4.2 Cross validation under the alternative
To investigate the cross validation method discussed above we performed simulations
for the scenarios assuming me = 10 and 60 prognostic variables (alternatives) among
m = 1000 and 6000 tested variables (hypotheses) setting the sample size to n = 50 per
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group. For the scenarios testing m = 1000 hypotheses we also investigate the cross vali-
dation procedure ﬁxing the per-group sample size to n = 100.
Table 4.1 shows the results of the cross validation procedure for the investigated examples
(mean values (standard deviations) and medians over 500 simulation runs) assuming that
the best achievable AUC∗ = 0.965. The αopt and AUC(αopt) values evaluated in the last
chapter are also given. If we compare the estimated αˆopt determined by the cross vali-
dation procedure to the true αopt we see that there may on average be large diﬀerences.
Therefore it has to be considered that the optima of the interpolated functions in the
diﬀerent scenarios are generally ﬂat, i.e. we get similar performances among a wide range
of α values. Furthermore, because of the skew distribution of αˆopt the medians over the
simulations are always closer to the αopt values (see Table 4.1).
The crucial ﬁnding is that the true FDR (determined from the simulations) in the se-
lection procedure is always close to the threshold αˆopt determined by cross validation
from the data. This behavior is related to theoretical results on the convergence of the
FDR simultaneously for diﬀerent thresholds (Genovese and Wasserman (2004)).
Despite the diﬀerences between αˆopt and αopt, the determined γˆopt and accordingly calcu-
lated αˆopt values are on average leading to true AUC(γˆopt) values for independent future
patients which are only slightly smaller than the evaluated AUC(αopt) over the whole
investigated examples. Note that the true AUC(γˆopt) is calculated using formula (3.3)
given γˆopt for selection. Increasing the samples size generally leads to smaller diﬀerences
between αˆopt and αopt and between AUC(γˆopt) and AUC(αopt). Thus, this cross validation
method seems to work under the alternative producing prognostic scores with a true AUC
in future patients close to the (for the diﬀerent scenarios) best possible AUC(αopt) when
using a multiple testing procedure controlling the FDR for selection.
From the cross validation procedure we also get a positively biased estimate ÂUC(γˆopt)
(compare formula (4.2)) of the true AUC(αopt) which is closer to the truth the larger the
eﬀect and sample sizes (Table 4.1). However, e.g. in the situation assuming me = 60
alternatives among m = 6000 tested hypotheses ÂUC(γˆopt) = 0.802 largely overestimates
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the true AUC(γˆopt) = 0.669.
A further important fact can be seen from the simulation results: the family wise type I
error rate (FWER) determined from the simulations is generally very large in selections
achieving a good prediction score (Table 4.1). This reﬂects the fact that allowing at least
one non-prognostic variable in the prediction score in order to detect more prognostic
variables leads to better performances in terms of the AUC.
In the situation of a small AUC∗ close to 0.8 (see results of the cross validation procedure
in Table 4.2) the cross validation procedure leads to smaller cross validated ÂUC(γˆopt)
values indicating a poorer prediction as compared to the situation of AUC∗ = 0.965. For
the resulting prediction scores, the same tendencies of the procedure are found as for
AUC∗ = 0.965. The procedure is again resulting in γˆopt and corresponding αˆopt values
Table 4.1: Results using the cross validation procedure: The true best choice of the
FDR (αopt) and the corresponding AUC(αopt) as well as results determined from the cross
validation procedure (means (standard deviations) and medians over 500 simulation runs):
the selection boundary γˆopt and the corresponding αˆopt, the true FDR and αˆopt,∞, the true
future AUC(γˆopt), the cross validated ÂUC(γˆopt) and the FWER for a varying number
of prognostic variables me, per-group sample sizes n and number of tested hypotheses m
assuming AUC∗ = 0.965.
m 1000 6000
me 10 60 10 60
n 50 100 50 100 50 50
αopt 0.170 0.014 0.824 0.475 0.250 0.896
AUC(αopt) 0.941 0.963 0.813 0.888 0.917 0.669
γˆopt 0.005 (0.01) 0.003 (0.01) 0.097 (0.09) 0.053 (0.05) 0.001 (0.001) 0.034 (0.05)
0.002 0.001 0.060 0.039 0.0005 0.013
αˆopt 0.243 (0.19) 0.149 (0.19) 0.615 (0.18) 0.451 (0.17) 0.286 (0.19) 0.812 (0.13)
0.190 0.061 0.643 0.459 0.250 0.835
FDR 0.254 (0.23) 0.165 (0.21) 0.604 (0.20) 0.444 (0.19) 0.297 (0.27) 0.783 (0.18)
0.200 0.091 0.645 0.462 0.226 0.817
αˆopt,∞ 0.256 (0.20) 0.154 (0.19) 0.613 (0.18) 0.452 (0.17) 0.311 (0.22) 0.801 (0.12)
0.191 0.065 0.636 0.460 0.260 0.820
AUC(γˆopt) 0.934 (0.02) 0.957 (0.01) 0.796 (0.04) 0.881 (0.02) 0.910 (0.03) 0.667 (0.03)
0.938 0.960 0.803 0.883 0.918 0.669
ÂUC(γˆopt) 0.956 (0.02) 0.966 (0.01) 0.868 (0.05) 0.916 (0.03) 0.945 (0.03) 0.802 (0.07)
0.959 0.967 0.873 0.918 0.948 0.810
FWER 0.760 0.586 0.984 0.998 0.720 0.980
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Table 4.2: Results using the cross validation procedure assuming a smaller
AUC∗: The true best choice of the FDR, αopt and the corresponding AUC(αopt) as
well as results determined from the cross validation procedure (means (standard deviations)
and medians over 500 simulation runs): the selection boundary γˆopt and the corresponding
αˆopt, the true FDR and αˆopt,∞, the true future AUC(γˆopt), the cross validated ÂUC(γˆopt)
and the FWER for a varying number of prognostic variables me, per-group sample sizes n
ﬁxing the number of tested hypotheses m = 1000 assuming AUC∗ = 0.80.
m 1000
me 10 60
n 50 100 50 100
αopt 0.794 0.493 0.919 0.893
AUC(αopt) 0.595 0.675 0.582 0.613
γˆopt 0.042 (0.06) 0.020 (0.03) 0.136 (0.23) 0.146 (0.23)
0.013 0.008 0.039 0.042
αˆopt 0.713 (0.22) 0.546 (0.24) 0.815 (0.16) 0.734 (0.17)
0.763 0.560 0.852 0.757
FDR 0.711 (0.28) 0.521 (0.29) 0.779 (0.20) 0.700 (0.20)
0.813 0.556 0.833 0.752
αˆopt,∞) 0.735 (0.18) 0.552 (0.23) 0.781 (0.09) 0.712 (0.14)
0.772 0.553 0.797 0.723
AUC(γˆopt) 0.598 (0.08) 0.676 (0.04) 0.551 (0.10) 0.587 (0.03)
0.600 0.678 0.559 0.593
ÂUC(γˆopt) 0.741 (0.07) 0.765 (0.05) 0.701 (0.07) 0.700 (0.05)
0.745 0.767 0.702 0.700
FWER 0.920 0.890 0.962 0.980 (0.07)
leading to prediction scores with AUC(γˆopt) values close to AUC(αopt).
4.3 Cross validation under the global null hypothesis
Under the global null hypothesis the cross validation procedure searching for decision
boundaries resulting in the "best" cross validated ROC-curve will generally produce a
score which is always useless for prediction of future outcomes. Note that only in a few
cases the FDR threshold determined by cross validation will not lead to selection of any
variable in the total sample. In this cases the AUC is set to 0.5 in the following. Note
that the true FDR is then 0.
Figures 4.1 show the distributions of the cross validated ÂUC(γˆopt) of the simulated
samples for the examples assuming me = 10 (ﬁrst row), 60 (second row) prognostic vari-
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ables as well as under the global null hypotheses (me = 0, third row) searching among
m = 1000 tested hypotheses (Figure from Goll (2008)). A sample size of n = 50 (ﬁrst
column) and n = 100 (second column) per group is applied. The histograms show that
in case of me = 10, ÂUC(γˆopt) is generally larger than 0.8 whereas under the global
null ÂUC(γˆopt) is generally below 0.8. Thus, one criterion could be the following: if the
ÂUC(γˆopt) resulting from the cross validation procedure is smaller than a value relevant
for practicable purposes then it seems to be preferable not to construct any score at all.
Note that applying a sample size of n = 100 per group (second column) there is no overlap
between the distributions under the alternative and under the global null hypothesis in
the simulated samples. Assuming me = 60 prognostic variables and ﬁxing n = 50 per
group only a small overlap can be seen if we are searching among 1000 hypotheses.
A further observation may be used for the decision to construct a score or not: un-
der the global null hypothesis generally αˆopt takes very large values exceeding 0.9. The
histograms of αˆopt under the alternative (ﬁrst row: me = 10, second row: me = 60) and
under the global null hypotheses (third row) are shown in Figure 4.2 for n = 50 (ﬁrst
column) and n = 100 (second column). Under the alternative αˆopt is varying largely,
although the average generally being much smaller than under the global null. Therefore,
a large αˆopt found in a real data set may be a good reason to decide against the score
because this may signal that we are under the global null hypotheses or that the sample
size is to small to detect the given eﬀects. Moreover in such a situation we have to expect
that most of the selected variables will not contribute to prediction anyway.
It also has to be mentioned that under the global null the mean estimate αˆopt calculated
from γˆopt may be much smaller than the true FDR. Table 4.3 summarizes the results of the
cross validation procedure under the global null hypothesis. Note that αˆopt,∞ is always 1
and the true AUC(γˆopt) is always 0.5. For comparison to the results under the alternative
see Table 4.1.
Looking at both criteria may help to decide for or against the prediction scores. The
Scatterplots for ÂUC(γˆopt) versus αˆopt in Figure 4.3 give an overview over the combina-
tion of both criteria. It can be seen that the cross validation based ÂUC(γˆopt) is varying
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less than the estimated αˆopt. If both criteria are large this may be a reason to decide
against the sore despite the large area under the curve because one may be conﬁdent that
a large number of non-prognostic variables are included in the score.
Increasing the number of tested hypotheses to m = 6000 in the situation of me = 10
(Figure 4.4: left plot) again ÂUC(γˆopt) is generally larger than 0.8. However, when ex-
pecting a larger number of prognostic variables with rather small eﬀect sizes (me = 60:
Figure 4.4 central plot) the distribution of ÂUC(γˆopt) largely overlaps the distribution
under the global null hypothesis (right plot). E.g., deciding to construct a score only if
the ÂUC(γˆopt) is larger than 0.8 would lead to a false negative decision in more than one
half of the cases. Constructing scores only if ÂUC(γˆopt) exceeds 0.7 would reduce the false
negative decisions, however increase the false positive decisions to 30% under the global
null hypotheses. Again, if the estimated ÂUC(γˆopt) is small this may be an indication
that in a speciﬁc sample we are close to the global null hypotheses or the sample size is
too small to detect the prognostic variables with their rather small eﬀects. αˆopt is again
varying largely under the alternative and under the global null (see histograms in Figure
4.5).
Summing up the results for m = 6000 it can be seen that if a small number of prog-
nostic variables with large eﬀect sizes is assumed (Figure 4.6, left plot), ÂUC(γˆopt) tends
to be large and αˆopt (despite the larger variation) tends to be small suggesting that there
may be a good prediction of the response of future patient to a speciﬁc therapy. For
me = 60 (see Figure 4.6, central plot) and under the global null (Figure 4.6, right plot)
ÂUC(γˆopt) tends to be small and αˆopt tends to be large which indicates that no good pre-
diction score for future patients can be determined from the given data. See also Table
4.3 for the results under the global null and Table 4.1 for the results under the alternative.
The histograms of ÂUC(γˆopt) in Figure 4.7, of αˆopt in Figure 4.8 and the scatterplots
in Figure 4.9 show the situation assuming a smaller AUC∗ of 0.8. In all three Figures
the situations of me = 10 (ﬁrst row), me = 60 (second row) and me = 0 (third row) are
considered for n = 50 (ﬁrst column) and n = 100 (second column). In the situation of a
small AUC∗ it may become diﬃcult to distinguish between the situations under the alter-
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native and under the global null if only small samples are used to search for a prediction
score. Under the alternative αˆopt varies largely and ÂUC(γˆopt) tends to be small. Thus,
larger sample sizes are needed to detect good prognostic scores. However, increasing the
sample size to n = 100 only slightly increases the performances of the determined predic-
tion scores. However again, the results of the cross validation procedure are reﬂecting the
poor performance of the detected prediction scores under the alternative and under the
global null (see Table 4.3). For comparison to the results of the cross validation procedure
under the alternative see Table 4.2.
Table 4.3: Results using the cross validation procedure under the global null hy-
potheses: means (standard deviations) and medians over 500 simulation runs of the selec-
tion boundary γˆopt and the corresponding αˆopt, the true FDR, the cross validated ÂUC(γˆopt)
and the FWER for a varying number of per-group sample sizes n and tested hypotheses m.
Note that αˆopt,∞ is always 1 and AUC(γˆopt) is always 0.5.
m 1000 6000
n 50 100 50
γˆopt 0.023 (0.03) 0.020 (0.03) 0.003 (0.003)
0.010 0.009 0.004
αˆopt 0.855 (0.18) 0.857 (0.18) 0.818 (0.21)
0.919 0.924 1.000
FDR 0.950 (0.22) 0.986 (0.18) 0.920 (0.27)
1.000 1.000 1.000
αˆopt,∞ 1.000 1.000 1.000
AUC(γˆopt) 0.500 0.500 0.500
ÂUC(γˆopt) 0.657 (0.08) 0.642 (0.06) 0.657 (0.08)
0.662 0.644 0.725
FWER 0.950 0.986 0.920
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Figure 4.1: Distribution of the cross validation based ÂUC(γˆopt) (500 simulation runs): me = 10 (ﬁrst
row), 60 (second row) or 0 (third row) among m = 1000 hypotheses. The sample size was
set to n = 50 per group (ﬁrst column) and n = 100 (second column). AUC∗ = 0.965 (Figure
from Goll (2008)).
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Figure 4.2: Distribution of the cross validation based αˆopt (500 simulation runs): me = 10 (ﬁrst row),
60 (second row) or 0 (third row) among m = 1000 hypotheses. The sample size was set to
n = 50 per group (ﬁrst column) and n = 100 (second column). AUC∗ = 0.965.
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Figure 4.3: Scatterplots of ÂUC(γ) vs. αˆopt (500 simulation runs): me = 10 (ﬁrst row), 60 (second
row) or 0 (third row) among m = 1000 hypotheses. The sample size was set to n = 50 per
group (ﬁrst column) and n = 100 (second column). AUC∗ = 0.965.
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Figure 4.4: Distribution of the cross validation based ÂUC(γˆopt) for selection using (100 simulated
steps): me = 10 (left plot), 60 (central plot) or 0 among m = 6000 (right plot)hypotheses.
The sample size was set to n = 50 per group. AUC∗ = 0.965.
Figure 4.5: Distribution of the cross validation based αˆopt (100 simulation runs): me = 10 (left plot),
60 (central plot) or 0 (right plot) among m = 6000 hypotheses. The sample size was set to
n = 50 per group. AUC∗ = 0.965.
Figure 4.6: Scatterplots of ÂUC(γˆopt) vs. αˆopt (100 simulation runs): me = 10 (left plot), 60 (central
plot) or 0 (right plot) among m = 6000 hypotheses. The sample size was set to n = 50 per
group. AUC∗ = 0.965.
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Figure 4.7: Cross validation assuming a smaller AUC∗: Distribution of the cross validation based
ÂUC(γˆopt) (500 simulation runs): me = 10 (ﬁrst row), 60 (second row) or 0 (third row)
among m = 1000 hypotheses. The sample size was set to n = 50 per group (ﬁrst column)
and n = 100 (second column). AUC∗ = 0.8
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Figure 4.8: Cross validation assuming a smaller AUC∗: Distribution of the cross validation based
αˆopt (500 simulation runs): me = 10 (ﬁrst row), 60 (second row) or 0 (third row) among
m = 1000 hypotheses. The sample size was set to n = 50 per group (ﬁrst column) and
n = 100 (second column). AUC∗ = 0.8.
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Figure 4.9: Cross validation assuming a smaller AUC∗: Scatterplots of ÂUC(γˆopt) vs. αˆopt (500
simulation runs): me = 10 (ﬁrst row), 60 (second row) or 0 (third row) among m = 1000
hypotheses. The sample size was set to n = 50 per group (ﬁrst column) and n = 100
(second column). AUC∗ = 0.8.
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4.4 Cross validation using the mean difference in score
values
In the following we will investigate another type of the cross validation method, where
the diﬀerence between the score values of the leaved out responder and the non-responder
is used instead of the cross validation function CFij. The ﬁnal selection boundary γˆopt is
than chosen such that it maximizes the mean value of the score diﬀerences over all nrnnr
possibilities of leaving out one responder and non-responder respectively.
Deﬁnition 4.4.0.6 Let fˆ(ij)(xr,i; γ) and fˆ(ij)(xnr,j; γ) be the score values of the left out
responder and non-responder respectively. fˆ(ij) was determined from the training sample
where the ith responder and the jth non-responder was left out and γ was used as selection
boundary. The mean diﬀerence between the score values is calculated as function of γ by:
M̂D(γ) =
1
nrnnr
nr∑
i=1
nnr∑
j=1
(fˆ(ij)(xr,i; γ)− fˆ(ij)(xnr,j; γ)) (4.4)
Deﬁnition 4.4.0.7 The best choice of the ﬁnal selection boundary, γˆopt, is then calculated
by:
γˆopt = arg max
γ
 1
nrnnr
nr∑
i=1
nr∑
j=1
(fˆ(ij)(xr,i; γ)− fˆ(ij)(xnr,j; γ))
 (4.5)
Table 4.4 shows the results applying the cross validation procedure using the diﬀerence in
score values for a varying number of prognostic variables me = 10, 60 or 0 and per-group
sample sizes n = 50 or 100, ﬁxing m = 1000 and assuming AUC∗ = 0.965. The mean
diﬀerence M̂D(γˆopt) tends to be small under the global null hypotheses and to be large
under the alternative. The histograms of M̂D(γˆopt) of the diﬀerent scenarios can be seen
in Figure 4.10. The ﬁgure shows a large overlap of the distributions under the alternatives
of me = 10 and 60 (ﬁrst and second row).
It can also be seen from Table 4.4 that the diﬀerences between αˆopt and αopt are much
larger than when using the Mann-Whitney U statistic. Thus, a smaller true AUC(γˆopt)
is achieved. αˆopt varies largely under the alternative, however, it also tends to be rather
large for me = 10 unlike applying the Mann-Whitney U statistic where small values of
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αˆopt were found. Figure 4.11 shows the distributions of αˆopt for the diﬀerent scenarios.
Under the global null αˆopt is generally larger than 0.9, similar to using the Mann-Whitney
U statistic. Figure 4.12 shows scatterplots of M̂D(γˆopt) versus αˆopt for the combination
of both criteria when using the mean diﬀerence in score values in the cross validation
procedure. For comparison to the cross validation procedure using the Mann-Whitney U
Statistic see Table 4.1 and Figure 4.3.
According to the given results one may conclude that using the Mann-Whitney U statistic
seems to work better than using the mean diﬀerence between the score values and we fur-
thermore get an estimate of the true AUC for future prediction (despite positively biased)
which seems to be a good criteria for the basic decision whether a prognostic score should
be constructed from the data or not. M̂D(γˆopt) has been found to be no good criterion
to reﬂect the performance of the determined prediction scores.
Table 4.4: Results using the cross validation procedure using the mean diﬀer-
ence in score values: The true best choice of the FDR, αopt and the corresponding
AUC(αopt) as well as results determined from the cross validation procedure (means (stan-
dard deviations) and medians over 500 simulation runs): the selection boundary γˆopt and
the corresponding αˆopt, the true FDR and αˆopt,∞, the true future AUC(γˆopt), the cross
validated M̂D(γˆopt) and the FWER for a varying number of prognostic variables me and
varying per-group sample sizes n, ﬁxing m = 1000 and assuming AUC∗ = 0.965.
m 1000
me 10 60 0
n 50 100 50 100 50 100
αopt 0.170 0.014 0.824 0.475
AUC(αopt) 0.941 0.963 0.813 0.888 0.500 0.500
γˆopt 0.044 (0.03) 0.041 (0.03) 0.241 (0.11) 0.130 (0.05) 0.040 (0.04) 0.041 (0.03)
0.036 0.032 0.241 0.131 0.030 0.033
αˆopt 0.702 (0.21) 0.668 (0.23) 0.811 (0.08) 0.682 (0.10) 0.910 (0.14) 0.925 (0.11)
0.762 0.731 0.818 0.690 0.974 0.977
FDR 0.684 (0.25) 0.667 (0.25) 0.794 (0.09) 0.669 (0.01) 0.940 (0.24) 0.978 (0.15)
0.778 0.762 0.818 0.696 1.000 1.000
αˆopt,∞ 0.699 (0.22) 0.674 (0.24) 0.798 (0.08) 0.675 (0.09) 1.000 1.000
0.783 0.762 0.820 0.697
AUC(γˆopt) 0.892 (0.04) 0.927 (0.02) 0.812 (0.02) 0.881 (0.01) 0.500 0.500
0.890 0.929 0.814 0.880
M̂D(γˆopt) 7.591 (1.44) 7.323 (0.89) 7.124 (1.60) 6.934 (0.97) 1.169 (0.84) 0.743 (0.47)
7.529 7.301 7.026 6.953 1.028 0.678
FWER 0.974 0.980 0.998 0.998 0.940 0.978
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Figure 4.10: Cross validation using the mean diﬀerence in score values: Distribution of the
cross validation based M̂D(γˆopt) (500 simulation runs): me = 10 (ﬁrst row), 60 (second
row) or 0 (third row) among m = 1000 hypotheses. The sample size was set to n = 50 per
group (ﬁrst column) and n = 100 (second column).
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Figure 4.11: Cross validation using the mean diﬀerence in score values: Distribution of the
cross validation based αˆopt (500 simulation runs): me = 10 (ﬁrst row), 60 (second row) or
0 (third row) among m = 1000 hypotheses. The sample size was set to n = 50 per group
(ﬁrst column) and n = 100 (second column).
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Figure 4.12: Cross validation using the mean diﬀerence in score values: Scatterplots of M̂D(γ)
vs. αˆopt (500 simulation runs): me = 10 (ﬁrst row), 60 (second row) or 0 (third row) among
m = 1000 hypotheses. The sample size was set to n = 50 per group (ﬁrst column) and
n = 100 (second column).
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5.1 Applying two-sided tests for selection
Up to now we performed one-sided two-sample z-tests for the selection of variables.
However, in practice generally two-sided tests are performed. The two-sided p-values
pi = 2(1 − Φ(|zi|)) are compared to the critical boundary γ which is equivalent to com-
pare the p-values pi = 1− Φ(|zi|) to the the critical boundary γ/2.
Theorem 5.1.0.2 In the two-sided case, for the p-values pi = 1 − Φ(|zi|) the procedure
applying the critical boundary γ/2 leads to the same results as the one-sided test under
the global null hypotheses. If under the alternative we assume constant eﬀect size among
the prognostic variables the two-sided tests lead to the same results if the eﬀect size (∆2)
is calculated by
∆2 =
z(1− γ
2
)− z(1− γ)√
n
2
+ ∆1.
(ignoring directional errors under the alternative). z(1−γ) denotes the (1−γ)-quantile of
the standard normal distribution and ∆1 is the corresponding eﬀect size in the one-sided
case.
Proof: Applying the same selection procedure the same power is achieved in the one and
two-sided test situation. Ignoring directional errors under the alternative:
1− β(γ) = 1− Φ√n
2
∆1,1
(z(1− γ)) = 1− Φ√n
2
∆2,1
(z(1− γ
2
)) = 1− β(γ/2)
Thus, the eﬀect size ∆2 can be easily calculated by solving the above equation.
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5.1.1 Simulation studies
Figure 5.1 shows the interpolated functions of the mean values of AUC(α) as a function
of α assuming me = 10 (dashed line) and 60 (dotted line) among m = 1000 hypotheses.
The sample size per group is set to n = 50. Note that ∆ = 0.811 for me = 10 and
∆ = 0.331 for me = 60. The grey curves show the results using one-sided tests and the
black curves applying two-sided tests for selection. The best choice expecting me = 10
among m = 1000 tested hypotheses in the two-sided test situation would be a slightly
larger αopt = 0.174 as compared to 0.170 in the one-sided test situation achieving on aver-
age a slightly smaller AUC(αopt) of 0.933 as compared to 0.941 in the one-sided situation.
If a larger number of prognostic variables with small eﬀects is assumed, the diﬀerence in
AUC(αopt) between the one and two-sided test situation is larger. Assuming 60 alterna-
tives among the m = 1000 tested hypotheses the values are αopt = 0.850 achieving an
average AUC(αopt) = 0.756 for applying two-sided tests as compared to αopt = 0.824 and
AUC(αopt) = 0.813 for the one-sided test situation.
The same tendencies can also be seen for the situation where the prognostic variables
are searched within m = 6000 variables (see Figure 5.2). Trough the whole examples
considered, in the two-sided case a slightly larger αopt is determined from the cross valida-
tion procedure achieving a slightly smaller AUC(αopt). A summary of the results for the
two-sided case can be seen in Table 5.1. For comparison to the one-sided case see Table
3.1.
Table 5.1: Two-sided test situation: Best choice of the FDR threshold αopt, the corresponding
true AUC(αopt) as well as the number of non-prognostic variables (ms0) and the number of
prognostic variables (mse) included in the prediction score.
m me ∆ n αopt AUC(αopt) m
s
0 m
s
e
1000 10 0.811 50 0.174 0.933 1.87 8.56
60 0.331 50 0.850 0.756 242.88 39.39
6000 10 0.811 50 0.252 0.904 2.64 6.89
60 0.331 50 0.936 0.625 631.37 26.34
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Figure 5.1: Two-sided test situation: Interpolated functions of mean values of AUC(α) over the
simulated samples (10000 simulation run) as a function of the FDR threshold α for selection
using a two-sided test assuming me = 10 (black dashed curve) and 60 (black dotted curve)
alternatives among m = 1000 tested variables. The corresponding one-sided results are
given as grey curves. The sample size per group was set to n = 50. AUC∗ = 0.965 is given
as solid horizontal line.
Figure 5.2: Two-sided test situation: Interpolated functions of mean values of AUC(α) over the
simulated samples (10000 simulation run) as a function of the FDR threshold α for selection
using a two-sided test assuming me = 10 (black dashed curve) and 60 (black dotted curve)
alternatives among m = 6000 tested variables. The corresponding one-sided results are
given as grey curves. The sample size per group was set to n = 50. AUC∗ = 0.965 is given
as solid horizontal line.
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5.1.2 Cross validation using two-sided tests
The cross validation procedure applying two-sided tests was investigated by simulation
only for the situations testing m = 1000 hypotheses. The sample size per group is ﬁxed
to n = 50. Simulations were performed for me = 10, 60 and under the global null.
The results of the cross validation procedure are shown in Table 5.2. Similar tendencies
for the determined prediction scores as compared to applying one-sided tests are found.
The cross validation procedure results in γˆopt and corresponding αˆopt values achieving a
future performance with mean AUC(γˆopt) values close to the true AUC(αopt). However,
in the two-sided case the diﬀerence between AUC(γˆopt) and AUC(αopt) is slightly larger
as when using one-sided tests. For the diﬀerence between αˆopt and αopt no such tendency
can be seen. For comparison to the one-sided case see Table 4.1.
Generally, as in the one-sided situation, values of the estimated ÂUC(γˆopt) are large
under the alternative and small under the global null. Figure 5.3 shows the histograms
of ÂUC(γˆopt) assuming me = 10 (left plot), me = 60 (central plot) and under the global
null (right plot). As compared to the one-sided situation a only slightly larger variation
of ÂUC(γˆopt) can be seen from the histograms (compare Figure 4.1).
Values of the determined αˆopt are as in the one-sided case largely varying under the alter-
native and are generally larger than 0.9 under the global null (see histograms in Figure 5.4
and Figure 4.2 for the one-sided case). Figures 5.5 show scatterplots for the combination
of both arguments for the investigated examples. Thus again we can conclude that both
criteria, ÂUC(γˆopt) and αˆopt, should be used for the basic decision for or against building
a prediction score from a given sample.
The results can be summarized similar to the one-sided case. The results of the cross
validation procedure are reﬂecting the performance of the determined scores leading to
larger ÂUC(αˆopt) and smaller αˆopt values under the alternative and to small ÂUC(αˆopt)
and large αˆopt values under the global null. Therefore, applying two-sided tests only
slightly reduces the performance of the determined scores.
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Figure 5.3: Cross validation using two-sided tests: Distribution of the cross validation based
ÂUC(γˆopt) (500 simulation runs) using a two-sided test: me = 10 (left plot), 60 (central
plot) or 0 (right plot) are assumed among m = 1000 hypotheses. The sample size is set to
n = 50.
Figure 5.4: Cross validation using two-sided tests: Distribution of the cross validation based αˆopt
(500 simulation runs) using a two-sided test: me = 10 (left plot), 60 (central plot) or 0
(right plot) are assumed among m = 1000 hypotheses. The sample size is set to n = 50.
Figure 5.5: Cross validation using two-sided tests: Scatterplot of ÂUC(γˆopt) vs. αˆopt (500 simu-
lation runs) using a two-sided test: me = 10 (left plot), 60 (central plot) or 0 (right plot)
are assumed among m = 1000 hypotheses. The sample size is set to n = 50.
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Table 5.2: Cross validation using two-sided tests: The true best choice of the FDR, αopt
and the corresponding AUC(αopt) as well as results determined from the cross validation
procedure: the selection boundary γˆopt and the corresponding αˆopt, the true FDR and αˆopt,∞,
the true AUC(γˆopt), the cross validated ÂUC(γˆopt) and the FWER for a varying number
of prognostic variables me. The per-group sample sizes is ﬁxed to n = 50 and m = 1000.
Under the alternative AUC∗ = 0.965.
me 10 60 0
αopt 0.174 0.850
AUC(αopt) 0.933 0.756 0.500
γˆopt 0.007 (0.01) 0.103 (0.11) 0.071 (0.11)
0.002 0.050 0.018
αˆopt 0.260 (0.21) 0.656 (0.19) 0.878 (0.17)
0.208 0.696 0.958
FDR 0.266 (0.25) 0.644 (0.21) 0.984 (0.13)
0.200 0.682 1.000
αˆopt,∞ 0.266 (0.22) 0.600 (0.19) 1.000
0.201 0.609
AUC(γˆopt) 0.924 (0.03) 0.743 (0.04) 0.500
0.931 0.747
ÂUC(γˆopt) 0.953 (0.02) 0.848 (0.05) 0.673 (0.08)
0.957 0.853 0.677
FWER 0.730 0.980 0.984
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5.2 Unequal effect sizes
Up to this point we assumed that all prognostic variables have the same eﬀect size. To
investigate situation under unequal eﬀect sizes, we now assume that, if the alternatives
holds, the eﬀects follow a uniform distribution (∆ ∈ (0, ∆˜]). The parameter ∆˜ for the
uniform distribution is searched such that the optimal linear prediction score, if known,
would lead to the benchmark AUC∗ (0.965). Thus, ∆˜ = 1.306 for me = 10 and ∆˜ = 0.566
for me = 60.
Secondly we assume that the eﬀects follow an exponential distribution. Again the pa-
rameter of the exponential distribution (λe) is searched such that the optimal linear
prediction score would lead to the benchmark AUC∗. Thus, λe = 1.374 for me = 10
and λe = 3.468 for me = 60. In the situation of exponential distributed eﬀect sizes and
uniform distributed eﬀect sizes, similar performances in terms of the true AUC(α) can be
seen (see Figure 5.6 and Table 5.3), since the eﬀect sizes to achieve AUC∗ do not diﬀer
largely between the two distributions.
Detecting the rather large eﬀects among the distributed variables results in a slightly
better performance of the determined scores as compared to the situation of equal eﬀect
sizes. Thus, αopt values are smaller and AUC(αopt) values are slightly larger as compared
to the case where equal eﬀect sizes are assumed.
However, because of the similarities to the situation of equal eﬀect sizes, we expect similar
tendencies for the cross validation procedure to determine γˆopt values leading on average to
AUC(γˆopt) values close to AUC(αopt) as well as giving a good reﬂection of the performance
of the determined scores by the estimates ÂUC(γˆopt) and αˆopt.
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Table 5.3: Unequal eﬀect sizes: Best choice of the FDR threshold αopt, the corresponding
true AUC(αopt) as well as the number of non-prognostic variables (ms0) and the number
of prognostic variables (mse) included in the prediction score assuming unequal eﬀect sizes
among the prognostic variables. The parameters of the distributions to achieve AUC∗ are
given. m = 1000, n = 50, AUC∗ = 0.965.
Distribution m me n ∆˜ or λe αopt AUC(αopt) ms0 m
s
e
uniform 1000 10 50 1.306 0.117 0.948 0.83 5.67
1000 60 50 0.566 0.588 0.834 34.42 22.98
exponential 1000 10 50 1.374 0.117 0.946 0.81 5.62
1000 60 50 3.468 0.575 0.834 32.04 22.48
Figure 5.6: Unequal eﬀect sizes: Interpolated functions of mean values of AUC(α) over the simulated
samples (10000 simulation run) as a function of the FDR threshold α for me = 10 (dashed
curves) and 60 (dotted curves) alternatives among m = 1000 tested variables. The eﬀect
sizes are assumed to follow uniform distributions (grey curves) or exponential distributions
(black curves). The sample size per group is set to n = 50. AUC∗ = 0.965 is given as solid
horizontal line.
80
6 Situation of unknown variances
6.1 Selection and prediction
Up to now we assumed that the variance (σ2 = 1) is known. However, in practice,
the variance is unknown and has to be estimated from the given data set. We now
will investigate the impact of estimating variances on the performance of the resulting
prediction scores by simulation. The selection method applying a multiple test with
threshold α for the FDR is now based on a one-sided two-sample t-test. Thus, the test
statistics, assuming that the unknown within-group variances are equal (σ2r,i = σ
2
nr,i =
σ2i = 1 for i = 1, ...,m) is:
ti = (x¯r,i − x¯nr,i)/(
√
(s2r,i + s
2
nr,i)/n), i = 1, . . . ,m (6.1)
where we again assume equal sample sizes per variable and group. s2r,i and s
2
nr,i are the
estimated variances from the samples of responders and non-responders respectively. The
decision is then based on the one-sided p-values
pi = 1− F2n−2(ti)
where F2n−2 is the central t-distribution with 2n− 2 degrees of freedom.
To calculate the score to predict a clinical outcome we now have to consider the esti-
mated variances in the prediction score (as in the classical discriminant function). The
weights of the selected variables in the prediction score have to be divided by the common
within groups variance estimate applied in the t-test:
s2i =
(nr,i − 1)s2r,i + (nnr,i − 1)s2nr,i
nr,i + nnr,i − 2 .
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Thus in our case of nr,i = nnr,i = n for i = 1, ...,m, s2i can be calculated as the simple
mean value of the within group variances of the group of responder and non-responder.
Deﬁnition 6.1.0.1 Assume that k ≤ m variables are selected to build a prediction score
(pj ≤ γ for j = 1, .., k). Let x¯r,j and x¯nr,j denote the sample means of the jth selected vari-
able of patients responding and not responding to therapy, respectively, and x = (x1, ..., xk)
the corresponding values of the selected variables in a future patient. The prediction score
is calculated as follows:
fˆ(x; γ) = cˆTx =
k∑
j=1
cˆjxj. (6.2)
where
cˆj =
x¯r,j − x¯nr,j
s2j
(6.3)
for the k selected variables with pj ≤ γ. All other variables are not included in the
prediction score (the weights in the score are set to 0).
If fˆ(x; γ) > b we predict a response, otherwise a non-response. Let the diagonal matrix
of the estimated variances of the k ≤ m selected variables be denoted by
Σˆk =

s21 0 . . . 0
0 s22
. . .
...
...
. . . . . . 0
0 . . . 0 s2k
 (6.4)
Note that we do not estimate the covariances (they are set to 0). Note also that the true
covariance matrix Σk of the k selected variables under our assumptions of independence
and (unknown) variance σ2 = 1 is equal to I.
Theorem 6.1.0.1 Let µa, a = r or nr denote the true mean vector of the k selected vari-
ables in a future responder or non-responder, respectively. Given the selection threshold
α and the estimated weights from the samples, the prognostic score follows two normal
distributions:
fˆ(x; γ) ∼ N [µa, σ2a] = N [cˆTµa, cˆT cˆ]
= N [(x¯r − x¯nr)T Σˆ−1k µa, (x¯r − x¯nr)T Σˆ−1k Σk(Σˆ−1k )T (x¯r − x¯nr)]
= N [(x¯r − x¯nr)T Σˆ−1k µa, (x¯r − x¯nr)T Σˆ−1k Σˆ−1k (x¯r − x¯nr)]
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Proof: The results can be derived by using theorem 2.1.0.7.
Theorem 6.1.0.2 Fixing the appropriate µa, a = r or nr, for the populations of re-
sponders and non-responders, respectively, the AUC for future independent populations is
calculated by:
AUC(α) =
∫ 1
0
{
1− Φ
[
z(1− w)− cˆ
T (µr − µnr)√
cˆT cˆ
]}
dw
=
∫ 1
0
1− Φ
z(1− w)− (x¯r − x¯nr)T Σˆ−1k (µr − µnr)√
(x¯r − x¯nr)T Σˆ−1k Σˆ−1k (x¯r − x¯nr)
 dw.
Proof: The results can be derived as in theorem 3.3.0.2.
6.2 Simulation studies
The situation of unknown variance is investigated by simulations for the scenarios search-
ing forme = 10 and 60 alternatives amongm = 1000 and 6000 hypotheses. The per-group
sample size in all investigated scenarios is set to n = 50. The eﬀect size is again triggered
by forcing the optimal ROC-curve through the benchmark point v = 1− w = 0.9. Thus
∆ remains the same as in the known variance case, for me = 10, ∆ = 0.811 and for
me = 60, ∆ = 0.331 to achieve AUC∗ = 0.965 of the ROC-curve crossing through the
benchmark point (v, 1 − w) = (0.9, 0.9). Again simulated mean values of AUC(α) for a
grid of α values with interval 0.01 are interpolated using splines. αopt is again determined
by optimizing the interpolated function.
Figure 6.1 shows the interpolated functions of the mean values of AUC(α) (10000 simu-
lation runs) for the unknown variance case expecting me = 10 (black dotted line) and 60
(black dashed line) among m = 1000 tested hypotheses. The corresponding results of the
known variance case are shown as grey lines. AUC∗ = 0.965 is shown as solid horizontal
line. The ﬁgure shows that the score using the estimated variances achieves only slightly
smaller performances in terms of AUC(α) as compared to the known variance case. For
me = 10, αopt = 0.174 on average achieves a performance of AUC(αopt) = 0.936. For
me = 60 the optimal threshold αopt = 0.832 achieves on average AUC(αopt) = 0.810.
Note that in the known variance case the values were AUC(αopt) = 0.941 and αopt = 0.17
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for me = 10 and AUC(αopt) = 0.813 and αopt = 0.824 for me = 60 (see results in Table
6.1 for the unknown variance case and Table 3.1 for comparison to the known variance
case). Thus, estimating the variances in the unknown case does only slightly decrease the
performance of the resulting scores. The selection threshold αopt slightly increases when
moving from the known to the unknown variance case.
Figure 6.2 shows the results for m = 6000 tested hypotheses. Again, estimating the vari-
ances only slightly decreases the performance of the resulting score as compared to the
known variance case. Testing m = 6000 hypotheses an optimal threshold of αopt = 0.226
leads on average to prediction scores with a mean performance of AUC(αopt) = 0.906 if
me = 10 prognostic variables are assumed. For me = 60 the values are αopt = 0.918 and
AUC(αopt) = 0.664. For the known variance case the values were AUC(αopt) = 0.917 and
αopt = 0.25 for me = 10 and AUC(αopt) = 0.669 and αopt = 0.895 for me = 60 (see also
Table 6.1 and 3.1 for more details).
Table 6.1: Unknown variance case: The best choice of the FDR threshold αopt, the corre-
sponding true AUC(αopt) as well as the number of non-prognostic variables (ms0) and the
number of prognostic variables (mse) included in the prediction score for a varying number
of and tested hypotheses m and prognostic variables me. n = 50 and AUC∗ = 0.965.
m me ∆ n αopt AUC(αopt) m
s
0 m
s
e
1000 10 0.811 50 0.174 0.936 1.93 8.49
60 0.331 50 0.832 0.810 274.60 49.71
6000 10 0.811 50 0.253 0.912 2.86 7.60
60 0.331 50 0.918 0.664 516.28 32.30
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Figure 6.1: Unknown variance case: Interpolated functions of mean values of AUC(α) (over 10000
simulation runs) for a varying FDR selection threshold α assuming me = 10 (black dashed
line) alternatives or 60 (black dotted line) among m = 1000 tested variables. The sample
size per group is set to n = 50. The corresponding known case is shown in grey lines.
AUC∗ = 0.965 is given as solid horizontal line.
Figure 6.2: Unknown variance case: Interpolated functions of mean values of AUC(α) (over 10000
simulation runs) for a varying FDR selection threshold α assuming me = 10 (black dashed
line) alternatives or 60 (black dotted line) among m = 6000 tested variables. The sample
size per group is set to n = 50. The corresponding known case is shown in grey lines.
AUC∗ = 0.965 is given as solid horizontal line.
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6.3 Cross validation
We investigated the cross validation procedure applying t-tests for the examples assuming
me = 10 and 60 among m = 1000 and 6000 candidate variables. The sample size per
group in the four examples is set to n = 50.
The general tendencies of the prognostic scores determined from the cross validation
procedure in the unknown variance case (results see Table 6.2) are similar as compared
to applying z-tests in the known variance case. The cross validation procedure deter-
mines γˆopt and corresponding αˆopt values leading to scores with an average performance
of AUC(γˆopt) values close to AUC(αopt).
Figure 6.3 shows the histograms of the estimated ÂUC(γˆopt) for the simulated samples as-
sumingme = 10 (left plot), 60 (central plot) and under the global null hypothesis (me = 0:
right plot) form = 1000. As in the situation of known variances the cross validation based
ÂUC(γˆopt) is small under the global null and large under the alternative indicating that
good scores can be constructed from the data if we are only searching within m = 1000
hypotheses. Again because of the skew distribution of αˆopt (see histograms in Figure
6.4) and the generally ﬂat optimum of the interpolated functions diﬀerences between αˆopt
and αopt can be seen. The medians are again closer to the true optimum. However, the
diﬀerences between αˆopt and αopt are slightly larger then in the known variance case. No
such tendency can be seen for the diﬀerences between ÂUC(γˆopt) and AUC(αopt). As
in the known variance case, αˆopt is varying largely under the alternative and under the
global null it is generally larger than 0.9 (see Figure 6.4 for histograms of αˆopt). However,
estimated αˆopt values are again close to the true FDR (refer Table 6.2).
Summing up the results under the unknown variance case it may again be useful to look
at the both criteria, the cross validation based ÂUC(γˆopt) and αˆopt, to decide, whether a
score should be constructed from a given sample sample or not. Figures 6.5 show scat-
terplots of ÂUC(γˆopt) versus αˆopt for m = 1000. Thus, if a selected score has a small
ÂUC(γˆopt) and a large αˆopt one should decide against the determined score. If a selected
score has a small ÂUC(γˆopt) and a small αˆopt one may conclude that the eﬀect sizes of the
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selected prognostic variables are too small for a good prediction of response of a patient
to a particular therapy. If ÂUC(γˆopt) is large and αˆopt is small the determined score may
have good prognostic abilities to predict the clinical outcome of a future patient. How-
ever, if ÂUC(γˆopt) is large and αˆopt is large too one may be careful because despite the
good prognostic ability an unrealistic large number of non-prognostic variables may be
included in the score. Thus, one may conclude that the sample size is to small to detect
the prognostic variables.
Figure 6.6 shows the histograms of ÂUC(γˆopt), Figure 6.7 the histograms of αˆopt and
Figure 6.8 scatterplots for ÂUC(γˆopt) versus αˆopt for the investigated scenarios searching
the prognostic variables among m = 6000 tested genes. The scores that can be deter-
mined from given samples by using a FDR-based selection procedures are performing good
if me = 10 prognostic variables are assumed and worse when me = 60 prognostic variables
are searched within the 6000 tested variables (see previous Section 6.2). The cross vali-
dation again mirrors this performances by leading to small ÂUC(γˆopt) values and to large
αˆopt values under the global null hypotheses and under the alternative of me = 60. In the
situation of me = 10, where rather good scores can be determined from the underlying
samples, the cross validation procedure ends in large ÂUC(γˆopt) values and in small αˆopt
values. For example, an average ÂUC(γˆopt) = 0.793 and αˆopt = 0.803 for me = 60 is
indicating a poor performance of the evaluated scores. An average ÂUC(γˆopt) = 0.993
and αˆopt = 0.375 for me = 10 is indicating a rather good performance of the evaluated
scores if we tolerate the fact that approximately 38% true null hypotheses are included in
the prediction score.
A summary of the results of the cross validation procedure under the alternative can
be seen in Table 6.2. A summary of the results of the cross validation procedure under
the global null hypothesis can be seen in Table 6.3. Note again that under the global null
AUC(γˆopt) is always equal to 0.5 and αˆopt,∞ is always equal to 1. Note also that again
under the global null larger diﬀerences between αˆopt and the true FDR can be seen as
under the alternative. Looking at the results from the simulations one may conclude that
estimating the variances only slightly decreases the quality of the determined prediction
scores as compared to the known variance case.
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Table 6.2: Cross Validation in the unknown variance case: The true best choice of
the FDR, αopt and the corresponding AUC(αopt) as well as results determined from the
cross validation procedure (means (standard deviations) and medians over 500 simulation
runs): the selection boundary γˆopt and the corresponding αˆopt, the true FDR and αˆopt,∞,
the true AUC(γˆopt), the cross validated ÂUC(γˆopt) and the FWER for a varying number
of prognostic variables me and tested variables m. The per-group sample sizes is ﬁxed to
n = 50. AUC∗ = 0.965.
m 1000 6000
me 10 60 10 60
n 50 50 50 50
αopt 0.174 0.832 0.253 0.918
AUC(αopt) 0.936 0.810 0.912 0.664
γˆopt 0.005 (0.01) 0.113 (0.12) 0.002 (0.004) 0.055 (0.07)
0.003 0.065 0.0007 0.025
αˆopt 0.258 (0.18) 0.632 (0.18) 0.375 (0.25) 0.803 (0.15)
0.213 0.663 0.313 0.858
FDR 0.249 (0.23) 0.615 (0.20) 0.383 (0.29) 0.811 (0.18)
0.182 0.649 0.348 0.868
αˆopt,∞ 0.264 (0.19) 0.626 (0.18) 0.388 (0.26) 0.820 (0.14)
0.220 0.648 0.344 0.869
AUC(γˆopt) 0.931 (0.02) 0.792 (0.04) 0.883 (0.05) 0.658 (0.03)
0.936 0.798 0.894 0.661
ÂUC(γˆopt) 0.952 (0.02) 0.864 (0.05) 0.933 (0.04) 0.793 (0.07)
0.955 0.867 0.938 0.797
FWER 0.744 0.988 0.820 0.980
Table 6.3: Cross Validation in the unknown variance case under the global null:
Results determined from the cross validation procedure (means (standard deviations) and
medians over 500 simulation runs): the selection boundary γˆopt and the corresponding αˆopt,
the true FDR and αˆopt,∞ (always 1) using the determined selection threshold, the true
AUC(γˆopt) (always 0.5), the cross validated ÂUC(γˆopt) and the FWER for a varying number
of prognostic variables me and tested variables m. The per-group sample sizes was ﬁxed to
n = 50. AUC∗ = 0.965.
m 1000 6000
γˆopt 0.046 (0.08) 0.049 (0.07)
0.012 0.014
αˆopt 0.909 (0.14) 0.961 (0.07)
0.978 0.994
FDR 0.980 (0.14) 1.000 (0.00)
1.000 1.000
αˆopt,∞ 1.000 1.000
AUC(γˆopt) 0.500 0.500
ÂUC(γˆopt) 0.659 (0.07) 0.667 (0.08)
0.663 0.675
FWER 0.980 0.998
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Figure 6.3: Unknown variance case: Distribution of the cross validation based ÂUC(γˆopt) (500
simulation runs) assuming unknown variance: me = 10 (left plot), 60 (central plot) or 0
(right plot) among m = 1000 hypotheses. The sample size is set to n = 50.
Figure 6.4: Unknown variance case: Distribution of the cross validation based αˆopt (500 simulation
runs) assuming unknown variance: me = 10 (left plot), 60 (central plot) or 0 (right plot)
among m = 1000 hypotheses. The sample size is set to n = 50.
Figure 6.5: Unknown variance case: Scatterplots of ÂUC(γˆopt) vs. αˆopt (500 simulation runs)
assuming unknown variance: me = 10 (left plot), 60 (central plot) or 0 (right plot) among
m = 1000 hypotheses. The sample size is set to n = 50.
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Figure 6.6: Unknown variance case: Distribution of the cross validation based ÂUC(γˆopt) (500
simulation runs) assuming unknown variance: me = 10 (left plot), 60 (central plot) or 0
(right plot) among m = 6000 hypotheses. The sample size is set to n = 50.
Figure 6.7: Unknown variance case: Distribution of the cross validation based αˆopt (500 simulation
runs) assuming unknown variance: me = 10 (left plot), 60 (central plot) or 0 (right plot)
among m = 6000 hypotheses. The sample size is set to n = 50.
Figure 6.8: Unknown variance case: Scatterplots of ÂUC(γˆopt) vs. αˆopt (500 simulation runs)
assuming unknown variance: me = 10 (left plot), 60 (central plot) or 0 (right plot) among
m = 6000 hypotheses. The sample size is set to n = 50.
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variables
7.1 Selection and prediction
Up to now we assumed independence across the candidate variables. In practice, one may
not always be conﬁdent that the tested variables are independent. However, assuming
correlation between variables (hypotheses) we use the same test statistics (6.1) for the in-
dividual variables as in the unknown variance case for selection using the FDR approach.
Thus, the decision is again based on the one-sided p-values pi = 1− F2n−2(ti) (one-sided
two-sample t-test) where ti is calculated using formula (6.1).
The eﬀect size ∆ of the prognostic variables is now depending on the correlation structure
in order to achieve the benchmark AUC∗ = 0.965.
Theorem 7.1.0.3 Let the prognostic variables be distributed according to N [∆,Σme ]. We
assume equal eﬀect sizes ∆ for the me prognostic variables. The required ∆ to achieve
a ROC-curve crossing through a benchmark point with ﬁxed values v for sensitivity and
1− w for speciﬁcity can be calculated by:
∆ =
z(w)− z(1− v)√
1TΣ−1me1
(7.1)
Proof: Under the assumption of equal eﬀect sizes among the prognostic variables, the
optimal score in this situation is again a linear score of all prognostic variables considering
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the covariance matrix (as in the discriminant analysis):
fˆ(x; γ) = 1TΣ−1mex.
Thus, the sensitivity can be calculated by
v = 1− Φ
z(1− w)− 1TΣ−1me∆√
1TΣ−1me1
 = 1− Φ(z(1− w)−∆√1TΣ−1me1) (7.2)
Solving equation (7.2) results in (7.1). Note again that Σme here denotes the true covari-
ance matrix of the me prognostic variables.
To investigate the impact of correlation between variables (hypotheses) on the perfor-
mance of the resulting linear prognostic scores we assume an autoregressive correlation
structure to exist among the variables, i.e. the correlation between hypothesis i and j is
given by
ρ|i−j| for some ρ ∈ (0, 1).
Thus, the m tested variables are distributed according to a m-dimensional normal distri-
bution where the covariance matrix Σ has an autoregressive correlation structure:
Σ =

1 ρ ρ2 ρ3 . . . ρm−1
ρ 1 ρ ρ2 . . . ρm−2
ρ2 ρ 1 ρ . . . ρm−3
...
. . . . . . . . . . . .
...
ρm−1 . . . . . . . . . . . . 1
 . (7.3)
We furthermore assume that the ﬁrst me variables are alternatives, i.e. the prognostic
variables are lying close to each other and thus are high correlated. The correlations
between the alternatives and the true null hypotheses, depending on the distance, may
be rather small. However, there is a large correlation between alternatives and true null
hypothesis lying close to the alternatives.
Note that we also assumed random distributed alternatives among the m tested vari-
ables. In this scenario the selected variables are nearly independent and thus results are
close to them determined for the independent case (data not shown).
As mentioned before the eﬀect size is depending on the correlation structure. Figure
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Figure 7.1: Correlated hypotheses: Minimal eﬀect size ∆ required to achieve a ROC-curve
crossing through the point where sensitivity and speciﬁcity are equal to 0.9 as a function of
the number of prognostic variables me.
7.1 shows the required ∆ to achieve the benchmark AUC∗ = 0.965 as a function of the
parameter ρ for the situation of an autoregressive correlation structure. For a negative
parameter ρ we get positive and negative correlations between the variables and thus also
between the alternatives. Therefore, only small eﬀect sizes are required to achieve AUC∗.
For a large positive ρ large eﬀect sizes are needed to achieve the benchmark AUC∗. In
the following simulation studies the parameter ρ is set to 0.6, −0.6 and 0.9. To achieve
a ROC-curve for future prediction that crosses the benchmark point (0.9, 0.9), a minimal
∆ of 1.422, 0.421 and 2.111 is required expecting 0.6, −0.6 and 0.9 if me = 10 prognostic
variables are assumed. For me = 60 a minimal ∆ of 0.646, 0.166 and 1.265 respectively
is required.
Deﬁnition 7.1.0.2 Assume that k ≤ m variables are selected for the construction of the
prognostic score whose p-values from the one-sided two-sample t-test were smaller than γ
(pj < γ). Let x¯r and x¯nr denote the sample means of the j = 1, ..., k selected variables
of patients responding and not responding to therapy respectively and x = (x1, ..., xk) are
the values of the corresponding variables of a future patient. To calculate the predictive
outcome, the estimated covariance matrix Σˆk of the k selected variables is considered in
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the the prediction score (as in the classical discriminant analysis). The score value than
is calculated by:
fˆ(x; γ) = (x¯r − x¯nr)T Σˆ−1k x (7.4)
Note that if the true covariance matrix would be known, the weight of one selected vari-
able in the score also depends on the eﬀect sizes of the two neighboring selected variables
and the distance to the two neighbors. The secondary diagonals of the inverse of the true
covariance matrix of the selected variables can be calculated by ρ|i−j|/(ρ2|i−j| − 1) where
| i− j | is the distance between the ith and jth variable. If | i− j | is large, this term is
close to zero.
According to the unknown variance case, the following results hold:
Theorem 7.1.0.4 Given a FDR selection threshold α (corresponding to the selection
boundary γ) and the estimated weights from the samples, the prognostic score follows two
normal distributions:
fˆ(x; γ) ∼ N [µa, σ2a] =
N [(x¯r − x¯nr)T Σˆ−1k µa, (x¯r − x¯nr)T Σˆ−1k Σk(Σˆ−1k )T (x¯r − x¯nr)]
where µTa , a = r or nr is the true mean vector of the k selected variables in a future
responder or non-responder, respectively, Σˆk is the estimated covariance matrix and Σk is
the true covariance matrix of the k selected hypotheses.
Proof: The results can be again derived by using theorem 2.1.0.7.
Theorem 7.1.0.5 Fixing the appropriate µa for the populations of responders and non-
responders, respectively, it is easy to get the AUC for future independent populations:
AUC(α) =
∫ 1
0
1− Φ
z(1− w)− (x¯r − x¯nr)T Σˆ−1k (µr − µnr)√
(x¯r − x¯nr)T Σˆ−1k ΣkΣˆ−1k (x¯r − x¯nr)
 dw. (7.5)
Proof: The results can again be derived as in theorem 3.3.0.2.
Note that because of the equal sample sizes in both groups Σˆk = (Σˆr + Σˆnr)/2 can
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again be calculated as the mean value over the two within group covariance matrices of
the selected k hypotheses. Note also that in the correlated case the whole covariance
matrix of the k selected variables is used whereas in the unknown variance case assuming
independence across hypotheses, only the estimated variances are included in the score.
However, for the prediction score we need the inverse of Σˆk. If too many hypotheses
are selected to build a prediction score, there may be situations where Σˆk can not be in-
verted. Thus, our second approach is to ignore the underlying correlation structure in the
construction of the prediction score estimating only the variances and setting the covari-
ances to 0. Σˆk is than estimated as in the unknown variance case assuming independence
across variables.
7.2 Simulation studies
The mean values of AUC(α) are evaluated within a grid of α values with interval 0.05
by simulation (5000 simulation runs). As in the previous sections, these mean values are
interpolated using splines. αopt is then again determined by maximizing the interpolated
function.
Over all investigated examples the sample size is set to n = 50 and m is set to 1000.
Figure 7.2 shows the example where me = 10 prognostic variables are searched within
m = 1000 candidate variables. The black curves show the interpolated functions for the
score applying only variance estimates in the weights whereas the grey curves show the
interpolated functions for the score for using the whole estimated covariance matrices for
the weights. The parameter ρ for the autoregressive correlation structure is assumed to
be 0.6 (dashed lines), −0.6 (dotdashed lines) and 0.9 (dotted lines). One can see from
the ﬁgure that for large α and large positive ρ no good estimate of the covariance matrix
can be achieved. The grey curves are falling below the black curves. For ρ = −0.6 (pos-
itive and negative correlations between the hypotheses) the covariance matrix may also
be invertible for larger values of α. The scores are achieving a slightly larger performance
for large α as compared to scores only estimating the variance. However, because of the
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small eﬀect size, both scores result in generally small performances as compared to AUC∗.
Note that the given grey curves can be only calculated from the simulated samples where
the estimated covariance matrix Σˆk is regular. For large positive ρ this is the case only in
a few simulated samples. Figure 7.4 shows the proportion of singular covariance matrices
among the simulated samples (5000 runs) applying ρ = 0.6 (dashed curves), −0.6 (dot-
dashed curves) and 0.9 (dotted curves) assuming me = 10 (Figure (A)) and 60 (Figure
(B)) alternatives among m = 1000 hypotheses. It can be seen that the larger the α values
the larger the probability that Σˆk is singular. Clearly the larger α the larger the number
of selected variables and the worse the estimation of the covariance matrix. For more than
100 selected variables (more variables than samples), no regular estimate of the covariance
matrix can be applied.
Assuming me = 60 among m = 1000 hypotheses (Figure 7.3, Figure 7.4 (B)) already
for smaller α, large numbers of variables are selected to construct a prediction score and
thus worse estimates of the covariance matrix are determined from the samples. The
grey curves in Figure 7.3 show a much smaller performance for the scores applying the
whole estimated covariance matrix as compared to the score only applying the variance
estimates (black curves). For negative ρ the diﬀerence between the performances of both
scores is smaller. However, over the whole investigated α values no good prediction score
can be constructed from the data. The average performance is always smaller than 0.6.
It seems that the second approach only applying variance estimates works better. Table
7.1 shows the results for the best choice of the threshold α if we construct a score based
on the unknown variance assumption despite the underlying correlation between the hy-
potheses. As discussed before if the correlations between prognostic variables are large
and positive, the eﬀect size ∆ has to be very large. As a consequence of the large eﬀect
sizes required to achieve AUC∗, a good prediction score can also be constructed from the
data in this case if only small sample sizes are available. If the correlation between prog-
nostic variables is either positive or negative the eﬀect sizes of each prognostic variable to
achieve AUC∗ can be very small. In such cases no good prediction scores can be achieved
over the whole range of investigated FDR thresholds (see also Figures 7.2, 7.3).
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Table 7.1: Correlated hypotheses: The best choice of the FDR threshold αopt, the correspond-
ing true AUC(αopt) as well as the number of non-prognostic variables (ms0) and the number
of prognostic variables (mse) included in the prediction score assuming a number of me = 10
and 60 prognostic variables among m = 1000 tested hypotheses. The parameter for the au-
toregressive correlation between hypotheses was set to ρ = 0.6, −0.6 and 0.9. The per group
sample size is set to n = 50 and the eﬀect size ∆ is calculated to achieve AUC∗ = 0.965.
m me ∆ n ρ αopt AUC(αopt) m
s
0 m
s
e
1000 10 1.422 50 0.6 0.024 0.961 0.27 10.00
0.421 50 -0.6 0.793 0.621 34.43 5.31
2.111 50 0.9 0.001 0.960 0.02 10.00
1000 60 0.646 50 0.6 0.225 0.950 15.52 50.94
0.166 50 -0.6 0.908 0.588 340.22 37.07
1.265 50 0.9 0.025 0.958 1.66 60.00
Figure 7.2: Correlated hypotheses: Interpolated functions of mean values of AUC(α) (over 5000
simulation runs) for a varying FDR selection threshold α assuming me = 10 prognostic
variables among m = 1000 tested variables. The parameter ρ for the autoregressive corre-
lation structure was set to 0.6 (dashed lines), −0.6 (dotdashed lines) and 0.9 (dotted lines).
Functions for scores using the whole covariance matrix (grey curves) or only variance esti-
mates (black curves) are given. The sample size is set to n = 50. AUC∗ = 0.965 is given as
solid horizontal line.
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Figure 7.3: Correlated hypotheses: Interpolated functions of mean values of AUC(α) (over 5000
simulation runs) for a varying FDR selection threshold α assuming me = 60 prognostic
variables among m = 1000 tested variables. The parameter ρ for the autoregressive corre-
lation structure was set to 0.6 (dashed lines), −0.6 (dotdashed lines) and 0.9 (dotted lines).
Functions for scores using the whole covariance matrix (grey curves) or only variance esti-
mates (black curves) are given. The sample size is set to n = 50. AUC∗ = 0.965 is given as
solid horizontal line.
Figure 7.4: Proportion of singular covariance matrices among the simulation runs for a varying FDR
threshold α. The parameter ρ for the autoregressive correlation structure was set to 0.6
(dashed line), −0.6 (dotdashed line) and 0.9 (dotted line). me = 10 (Figure (A)) and 60
(Figure (B)) prognostic variables were assumed among m = 1000 tested hypotheses
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Note again that in the case of correlation between hypotheses we propose the unknown
variance assumption standardizing the weights in the score by respective variance esti-
mates. If a large number of variables are included in the score and a small sample size
is applied, Σˆk can not always be inverted. Choosing the simple additive score with stan-
dardized weights leads to only slightly poorer performances in terms of the AUC than
considering the whole estimated covariance matrix (if possible). This is a reason why the
simple additive score has attracted a lot of attention in applications.
In the situation of correlated variables, generally the same tendencies for the prognos-
tic scores determined by the cross validation procedure can be found as in the situation
of independence between hypotheses. Because of the ﬂat optimum of the interpolated
functions for large positive ρ (see Figures 7.2, 7.3) again there may be large diﬀerences
between αˆopt determined from the cross validation procedure and αopt. However, again the
determined γˆopt and corresponding αˆopt values are leading to a mean future performance
in terms of AUC(γˆopt) which is close to AUC(αopt) (see Table 7.2 for the cross validation
results of the investigated examples).
Despite the underlying correlation structure the cross validation procedure (only con-
sidering the estimated variances in the score) seem to work well ending in larger cross
validation based ÂUC(γˆopt) values and small αˆopt values if the alternative holds and in
small cross validation based ÂUC(γˆopt) values and large αˆopt values if the global null hy-
pothesis is true (see histograms of ÂUC(γˆopt) in Figure 7.5 and of αˆopt in Figure 7.6).
Assuming ρ = 0.6 and 0.9 the eﬀect sizes have to be very large to achieve the benchmark
AUC∗. Thus the cross validation procedure ends in ÂUC(γˆopt) values larger than 0.9
(Figure 7.5 ﬁrst and third row). For ρ = −0.6 the eﬀect size ∆ is very small in order
to achieve AUC∗. Fortunately, values of ÂUC(γˆopt) are also small under the alternative
indicating that no good prediction score can be determined with the given eﬀect and
sample sizes (Figure 7.5 second row).
αˆopt is varying large, however, being on average small for ρ = 0.6 and 0.9 due to the
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large eﬀect sizes. For example, for ρ = 0.9, αˆopt on average is 0.003 assuming me = 10
prognostic variables. For ρ = −0.6 and assuming me = 10 an average αˆopt = 0.588 is
indicating that the resulting score includes more than 50% non-prognostic variables. For
me = 60 more than 80% non-prognostic variables can be expected in the prediction score.
Table 7.2 summarizes the results under the alternative.
Table 7.3 shows the results of the cross validation procedure under the global null hypoth-
esis. Under the global null, ÂUC(γˆopt) is generally smaller than 0.7 and αˆopt is generally
larger than 0.9 (see medians in table Table 7.3). This indicates that we can expect that
more than 90% variables without prognostic ability are included in the score and that the
performance of the selected score is very poor. In this situation one may conclude that
no prediction score should be selected from the given data.
The cross validation procedure seems to work also in the situation of correlated hypotheses
ending at ÂUC(γˆopt) and αˆopt values giving a good evaluation of the underlying prediction
score. Again the conclusion is that both criteria, ÂUC(γˆopt) and αˆopt should be consid-
ered to decide whether a score should be constructed from a given data set or not. Figure
7.7 shows scatterplots of ÂUC(γˆopt) vs. αˆopt for all investigated examples. However, one
contradiction remains, the diﬀerences between the estimated αˆopt and the true FDR are
slightly larger under the correlated case than under the independent case (see Tables 7.2
and 7.3).
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Table 7.2: Cross Validation in the correlated case: The true best choice of the FDR,
αopt, and the correspondingAUC(αopt) as well as results determined from the cross validation
procedure: the selection boundary γˆopt and the corresponding αˆopt, the true FDR and αˆopt,∞,
the true AUC(γˆopt), the cross validated M̂D(γˆopt) and the FWER for a varying number of
prognostic variables me. The number of tested variables is set to m = 1000. The per-group
sample size is ﬁxed to n = 50. ρ = 0.6, −0.6 and 0.9. AUC∗ = 0.965.
me 10 60
ρ 0.6 -0.6 0.9 0.6 -0.6 0.9
∆ 1.422 0.421 2.111 0.646 0.166 1.265
αopt 0.024 0.793 0.001 0.225 0.908 0.025
AUC(αopt) 0.961 0.621 0.960 0.950 0.588 0.958
γˆopt 0.007 (0.01) 0.013 (0.01) 0.00004 (0.0001) 0.030 (0.03) 0.292 (0.27) 0.0096 (0.01)
0.002 0.007 0.0000005 0.019 0.167 0.0018
αˆopt 0.220 (0.26) 0.588 (0.25) 0.003 (0.009) 0.281 (0.17) 0.888 (0.07) 0.103 (0.14)
0.128 0.634 0.0000505 0.254 0.891 0.024
FDR 0.243 (0.26) 0.579 (0.31) 0.021 (0.07) 0.278 (0.19) 0.857 (0.06) 0.110 (0.16)
0.167 0.692 0.000 0.250 0.861 0.016
αˆopt,∞ 0.226 (0.26) 0.607 (0.21) 0.004 (0.01) 0.283 (0.17) 0.858 (0.05) 0.105 (0.14)
0.131 0.658 0.0000495 0.255 0.854 0.027
AUC(γˆopt) 0.957 (0.01) 0.618 (0.11) 0.960 (0.001) 0.947 (0.01) 0.584 (0.01) 0.957 (0.002)
0.959 0.624 0.960 0.948 0.586 0.957
ÂUC(γˆopt) 0.964 (0.02) 0.744 (0.07) 0.960 (0.01) 0.957 (0.02) 0.661 (0.07) 0.960 (0.02)
0.966 0.751 0.960 0.959 0.667 0.960
FWER 0.648 0.826 0.110 0.986 0.998 0.542
Table 7.3: Cross Validation in the correlated case under the global null: Results
determined from the cross validation procedure: the selection boundary γˆopt and the corre-
sponding αˆopt, the true FDR using the determined selection threshold, αˆopt,∞ (always 1) the
true AUC(γˆopt) (always 0.5), the cross validated ÂUC(γˆopt) and the FWER for a varying
number of parameters for the autoregressive correlation ρ. The number of tested variables
is set to m = 1000. The per-group sample size is ﬁxed to n = 50. AUC∗ = 0.965.
ρ 0.6 -0.6 0.6
γˆopt 0.034 (0.06) 0.044 (0.08) 0.040 (0.08)
0.006 0.009 0.007
αˆopt 0.812 (0.22) 0.841 (0.20) 0.770 (0.27)
0.916 0.935 0.904
FDR 0.972 (0.17) 0.964 (0.19) 0.886 (0.32)
1.000 1.000 1.000
αˆopt,∞ 1.000 1.000 1.000
AUC(γˆopt) 0.500 0.500 0.500
ÂUC(γˆopt) 0.650 (0.07) 0.662 (0.07) 0.604 (0.07)
0.659 0.670 0.607
FWER 0.972 0.964 0.886
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Figure 7.5: Correlated hypotheses: Distribution of the cross validation based ÂUC(γˆopt) (500 sim-
ulation runs) assuming correlation between variables: me = 10 (ﬁrst column), 60 (second
column) or 0 (third column) are assumed among m = 1000 hypotheses. ρ = 0.6 (ﬁrst row)
−0.6 (second row) and 0.9 (third row) is assumed. The sample size is set to n = 50.
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Figure 7.6: Correlated hypotheses: Distribution of the cross validation based αˆopt (500 simulation
runs) assuming correlation between variables: me = 10 (ﬁrst column), 60 (second column)
or 0 (third column) are assumed among m = 1000 hypotheses. ρ = 0.6 (ﬁrst row) −0.6
(second row) and 0.9 (third row) is assumed. The sample size is set to n = 50.
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Figure 7.7: Correlated hypotheses: Scatterplots of ÂUC(γˆopt) vs. αˆopt (500 simulation runs) as-
suming correlation between variables: me = 10 (ﬁrst column), 60 (second column) or 0
(third column) are assumed among m = 1000 hypotheses. ρ = 0.6 (ﬁrst row) −0.6 (second
row) and 0.9 (third row) is assumed. The sample size is set to n = 50.
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To evaluate the cross validation procedure we used three data sets summarized and pre-
processed by Pavlidis et al. (2003) and a data set investigated in Tian et al. (2003). Note
that because of the large number of investigated genes in the four investigated data sets
(> 6000) it was not possible to apply the forward logistic regression in SAS 9.1. due to
lack of memory space.
8.1 Data set: Tian et al. (2003)
First we investigate the data set taken from Tian et al. (2003) and pre-processed by Jeﬀery
et al. (2006). In this study, patients with multiple myeloma were investigated. 36 patients
in whom focal lesions of bone could not be detected were compared to 137 patients with
such lesions. They subjected puriﬁed plasma cells from the bone marrow of patients with
newly diagnosed multiple myeloma to oligonucleotide microarray proﬁling. The data was
generated using Aﬀymetrix human U95A. 12625 probe sets were investigated. In order to
construct a prediction score we compare the two independent groups using the p-values
of the two-sided t-tests.
The cross validation procedure determines an α̂opt of 0.0124 leading to a score includ-
ing 101 probe sets. Figure 8.1 (A) shows ÂUC(γ) determined from cross validation as
a function of the selection boundary γ for the individual p-values. Figure (B) shows a
histogram of the 12625 two-sided p-values. ÂUC(αˆopt) = 0.786 is indicating a rather
limited performance for a future independent patient. However, the result indicates that
in the example one may be conﬁdent that the selected score will not contain a noticeable
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Figure 8.1: Results of the cross validation procedure for the data set investigated in Tian et al. (2003).
ÂUC(γ) determined from cross validation as a function of the threshold γ for the individual
p-values is shown in Figure (A). Figure (B) shows a histogram of the individual p-values.
fraction of non-prognostic genes. A summary of the results can be seen in Table 8.1.
8.2 Data set: Golub et al. (1999)
In the study by Golub et al. (1999) gene expression proﬁles of two types of leukaemia were
compared. Samples were derived from 47 patients with acute lymphoblastic leucemia
(ALL) and 25 patients with acute myeloblastic leucemia (MLL). RNA prepared from
bone marrow mononuclear cells was hybridized to high-density oligonucleotide microar-
rays, produced by Aﬀymetrix. 7129 probe sets were investigated.
To construct a prediction score we again compare the two independent groups (ALL
vs. MLL) using the p-values of the two-sided t-tests. A summary of the results of the
cross validation procedure can be seen in Table 8.1. Figure 8.2 (A) shows ÂUC(γ) deter-
mined from cross validation as a function of the threshold γ for the individual p-values.
Figure (B) shows a histogram of the two-sided p-values. From the histogram one can see
that for approximately 1500 probe sets the corresponding p-values are smaller than 0.02.
The cross validation procedure determines a very small αˆopt = 0.0001 achieving a cross
validation based ÂUC(γˆopt) = 0.988. This result may be an indication that with the se-
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Figure 8.2: Results of the cross validation procedure for the data set investigated in Golub et al. (1999).
ÂUC(γ) determined from cross validation as a function of the threshold γ for the individual
p-values is shown in Figure (A). Figure (B) shows a histogram of the individual p-values.
lected genes we may get a very good determination between the two investigated groups.
The determined prediction score includes 103 genes and the small αˆopt indicates that the
selected score may not contain a large fraction of non-prognostic genes.
8.3 Data set: Eaves et al. (2002)
In the study of Eaves et al. (2002) they used high-density oligonucleotide arrays to measure
the relative expression levels of 39114 genes of mouse spleen and thymus. We investigated
a distinction (spleen vs. thymus) that was not examined in the original publication but
have been already discussed by Pavlidis et al. (2003). We used the data set preprocessed
by Pavlidis et al. (2003).
Again we performe a two-sided t-test to determine candidate variables for the construction
of a prognostic score that distinguishes between genes corresponding to spleen or thymus
of mice. Figure 8.3 (B) shows a histogram of the two-sided p-values. The distribution of
the p-values shows that only a few p-values are very small and that a large number p-
values is larger than 0.8. There is no explanation for the strange distribution of p-values.
Despite the strange distribution of the p-values we investigated the cross validation struc-
ture for this data set. Looking at the results of the cross validation procedure (see Figure
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Figure 8.3: Results of the cross validation procedure for the data set investigated in Eaves et al. (2002).
ÂUC(γ) determined from cross validation as a function of the threshold γ for the individual
p-values is shown in Figure (A). Figure (B) shows a histogram of the individual p-values.
8.3 (A) and Table 8.1) one may get an indication that there is no good discrimination
between the two groups. αˆopt is estimated with 1 leading to ÂUC(γˆopt) = 0.562. However,
the sample size in both groups is 12 such that the bad result may also be an indication
that the sample size is too small to detect the prognostic variables. Note also that only 5
genes were included in the resulting prediction score.
8.4 Data set: Callow et al. (2000)
Callow et al. (2000) tried to identify genes with altered expression levels in knockout
mice compared to control mice. Based on the assumption that severe alterations in the
expression of genes known to be involved in high-density lipoprotein (HDL) metabolism
may aﬀect the expression of other genes, they screened an array of 6384 mouse expressed
sequence tags for altered gene expression in the livers of one line of mice with dramatic
decreases in HDL plasma concentrations. Labeled cDNA from livers of apoAI-knockout
mice and control mice were cohybridized to microarrays. A very small sample of 8 knock-
out and 8 control mice was used.
Again two-sided two-sample t-tests are used to determine candidates to construct a pre-
diction score (see histogram of the two-sided p-values in Figure 8.4 (B)). The results of
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the cross validation procedure (see Figure 8.4 (A) and Table 8.1) give an indication that
a very good discrimination between the two groups can be achieved with a few genes.
The prognostic score determined by using the cross validation procedure includes only 3
genes in the determined score. The cross validation based ÂUC(γˆopt) is set to 1 indicat-
ing complete discrimination of the two groups. αˆopt = 0.0011 also indicates a vary small
proportion of non-prognostic genes.
Figure 8.4: Results of the cross validation procedure for the data set investigated in Callow et al. (2000).
ÂUC(γ) determined from cross validation as a function of the threshold γ for the individual
p-values is shown in Figure (A). Figure (B) shows a histogram of the individual p-values.
Table 8.1: Real data applications: Results of the cross validation procedure determined for
real data sets are shown. The reference of the corresponding paper, the group sample sizes
(n1/n2), the number of investigated genes and the type of array which was used for the
study, either cDNA for data that was collected using two-color "cDNA" microarrays or
"oligo" for Aﬀymetrix-type oligonucleodtide arrays. The best selection boundary γˆopt, the
corresponding estimated FDR αˆopt and pˆi0 as well as the cross validated ÂUC(γˆopt) and
the number of genes included in the prediction score (]) determined by the cross validation
procedure are given.
Data Description Cross validation
Reference (n1/n2) Genes Type γˆopt αˆopt pˆi0 ÂUC(γˆopt) ]
Tian et.al. (2003) 137/36 12625 oligo 0.00034 0.0125 0.294 0.786 101
Golub et.al. (1999) 47/25 7129 oligo 0.000002 0.0001 0.213 0.988 103
Eveas et.al. (2002) 12/12 39114 oligo 0.00150 1.0000 0.545 0.562 5
Callow et.al. (2000) 8/8 6384 cDNA 0.000005 0.0015 0.143 1.000 3
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To get a good prediction (in terms of the ROC-Curve) of a clinical outcome with a single
prognostic variable the eﬀect size has to be very large. Therefore only small samples
are suﬃcient to identify this single variable among a large number of candidates by a
statistical comparison between responder and non-responder. However, this is not the
typical situation we are faced with. Generally we are confronted with large numbers of
candidates, few of them being related with a clinical outcome having rather small eﬀect
sizes. Selection and estimation are often based on samples dramatically smaller than the
number of candidates so that the asymptotic of model selection procedures does not apply.
The estimates of the selected weights (and the ROC-curves) are biased and highly variable.
We performed simulations using multiple tests controlling the FDR for selection of vari-
ables for future prediction. We additionally performed simulations using the binary logis-
tic regression model for the investigated problem. In the situation where the sample sizes
are much smaller than the number of tested variables the simple method of additive scores
following a selection of variables by multiple testing based on a FDR threshold general
outperforms selection by forward stepwise logistic regression. The appearing problem of
complete separation of data points results in selecting only a few alternatives for future
prediction and thus to a poor performance. If the number of prognostic variables is rather
small and they have suﬃciently large eﬀects, which, if all would be known, would lead to
a large AUC, then the selected scores may have good properties over a range of diﬀerent
FDR values used for selection. Under the alternative in general it seems to be preferable
to use rather liberal selection criteria accepting that a certain number of non-prognostic
variables is contained in a score to get the advantage of catching more eﬀective ones. For
large samples the predictive ability of the estimated score does not depend strongly on
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the number of selected variables. For large sample sizes the weights for non-prognostic
variables contained in the score are estimated more precisely and, despite of the selection
procedure, will tend to be the ones closed to zero with a small contribution overall. Hence
the performance of the score will not vary much for diﬀerent numbers of non-prognostic
variables contained in the score: More liberal selection criteria will lead to scores contain-
ing more nuisance variables (with low weights) but also more variables related with the
clinical outcome (with large weights). This mirrors the fact that asymptotically for large
sample sizes, multiple test based selection procedures may be consistent procedures for
model selection. It also has to be mentioned, that if a very large number of prognostic
variables is expected working together with rather small individual eﬀect sizes and only
small sample sizes are available, the selection methods based on univariate tests also per-
form worse, although leading to a larger AUC for future prediction as using the forward
logistic regression.
The cruical scenario in the small sample case is the global null hypothesis: There are
no prognostic variables at all and hence any selection will lead to completely uninfor-
mative prediction scores. To protect against erroneous selection in this situation the
FDR applied for selection should be rather small. Under the global null hypothesis con-
trol of the FDR also controls the probability of the selection of any variables. Under the
alternative, however, we found that rather larger FDR values should be used for selection.
One way to determine the FDR-value to be applied for selection in a concrete sample
in order to achieve good prediction by a prognostic score in terms of the AUC is to esti-
mate the selection boundaries by cross validation. The discussed method seems to work
if we really are in a situation that we deal with variables with a high prognostic potential
which leads to rather large cross validation estimates of the AUC, whereas under the
global null hypothesis these estimates are rather small.
However the situation gets much worse if we look at situation when the prognostic vari-
ables are not suﬃciently large that the optimal score (if known) would lead to a ROC-curve
crossing the point with sensitivity and speciﬁcity of 0.9 (with a theoretically best achiev-
able AUC∗ = 0.965 which was the benchmark in most of our investigations). For AUC∗
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close to values of 0.8, which are values, e.g., achievable in predicting hospital mortality
from scores based on a set of variable measured in patients at admission to an intensive
care unit (and constructed in large training samples), the selection procedure will lead to
poor scores. However, the cross validation procedure still seem to work well by identifying
scores with an estimated AUC close to the best AUC achievable by a FDR-based selection
procedure in the sample.
With this cross validation method we may achieve several goals:
1. We determine an optimal selection threshold for selection of variables to be used
in a prediction score for future sample units which provides a good performance in
terms of the ROC-curve.
2. We get a positively biased estimate of the AUC which is closer to the true AUC for
prediction the larger the eﬀect and sample sizes.
3. If the estimate of the AUC is small this may be an indication that in a speciﬁc
sample we are close to the global null hypotheses or the eﬀect sizes are to small for
the given sample size.
4. We also get an estimate of the FDR among the selected variables which is close to
the true FDR (with a direction depending on the magnitude of the FDR).
The speciﬁc contribution of this diploma thesis was to investigate the properties of the
proposed procedure in case deviations from the simple assumptions of one-sided tests for
independent normally distributed variables with common known variance: two-sided tests,
unknown variance, distributed alternatives and correlation between variables. The gen-
eral tendencies found for the simple one-sided known variance case still apply under more
general model assumptions. The performances of the determined prognostic scores only
slightly decrease as compared to the known variance case. Assuming an autoregressive
correlation structure between the candidate variables, the eﬀect size of the alternatives
and thus also the performance of the determined scores depend on the parameter ρ. As-
suming a large positive ρ the eﬀect size has to be very large in order to achieve AUC∗.
Thus, a good prediction score can be constructed from the data in this case if only small
sample sizes are available. If the correlation is either positive or negative (negative ρ),
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the eﬀect size to achieve AUC∗ can be very small. Thus, no good prediction scores can
be achieved if small sample sizes are applied. However, also in the correlated case the
cross validation procedure is reﬂecting the performance of the prediction scores with the
estimated ÂUC(γˆopt) and αˆopt values.
Our ﬁndings show that simple method can lead to well performing prediction scores even
in rather small samples, given that we deal with a problem where prognostic variables
with noticeable eﬀects are involved. However, they also tell us that there is no such thing
as a free lunch in a statistically odd problem of dealing with large numbers of variables
considerably exceeding sample sizes.
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A Abstract
Multiple testing has been applied for selecting prognostic variables related with a clinical
outcome (response to therapy) from a large number of candidates in small samples of
"responding" or "non-responding" patients which are then used to estimate a score for
prediction in future patients. We evaluated selection based on control of the false dis-
covery rate (FDR) to build a linear score by considering the resulting receiver operating
characteristic (ROC) for independent prediction of future patients. We simulated diﬀer-
ent scenarios with varying number of tested candidates, proportion of prognostic variables
and sample sizes. Underlying eﬀect sizes were determined such that optimal prediction,
if known, would lead to a ROC-curve crossing through a benchmark point with pre-ﬁxed
values of sensitivity and speciﬁcity. We show that the "best" FDR-threshold which pro-
vides the ROC-curve with the largest area under the curve (AUC) varies largely over the
diﬀerent parameter constellation not known in advance.
Hence, cross validation is proposed to determine the optimal selection threshold in a
speciﬁc sample. This procedure (i) allows to choose an appropriate selection criterion,
(ii) results in an estimate of the AUC for future prediction (though positively biased) and
(iii) provides an estimate of the FDR close to the true FDR. Moreover, low estimates of
the cross validated AUC and large estimates of the cross validated FDR may indicate a
lack of suﬃciently prognostic variables and/or too small sample sizes.
Keywords: Variable Selection; False Discovery Rate; Receiver Operating Characteristic
Curve; Cross Validation
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B Kurzfassung
In dieser Arbeit wird die Selektion von Variablen die (in Wahrheit) einen Einﬂuss auf
einen klinischen Endpunkt (z.B. den Ausgang einer bestimmten Therapie) haben aus
einer großen Menge von Kandidatenvariablen mit Hilfe von nur kleinen Stichproben von
Patienten, die auf die Therapie reagieren bzw. nicht reagieren, behandelt. Die Selektion
basiert auf einer multiplen Testprozedur die die False Discovery Rate (FDR) einhält. Mit
jenen, mit Hilfe der multiplen Testprozedur selektierten, Variablen soll ein prognostis-
cher Score konstruiert werden, mit dem man den klinischen Endpunkt eines zukünftigen
Patienten vorhersagen kann. Dieser lineare Score wird aufgrund der resultierenden Re-
ceiver Operating Characteristic Curve (ROC) bewertet. Die Selektionsgrenze für die FDR,
welche die beste Fläche unter der ROC-Kurve (AUC) liefert ist allerdings von unbekan-
nten Parametern wie z.B. der Eﬀektgröße oder der Anzahl der Variablen, die tatsächlich
einen Einﬂuss auf den klinischen Endpunkt haben stark abhängig.
Um in einem speziﬁschen Datensatz nach der optimalen Selektionsschranke zu suchen
wird die Verwendung einer Prozedur zur Kreuzvalidierung vorgeschlagen. Diese Prozedur
(i) ermittelt ein adäquates Selektionskriterium für die multiple Testprozedur, (ii) berech-
net einen (positiv verzerrten) Schätzer für die AUC für zukünftige Prognosen und (iii)
liefert einen Schätzer für die FDR, der nahe der wahren FDR ist. Darüber hinaus geben
niedrige Werte der ermittelten kreuzvalidierten AUC und große Werte der kreuzvalidierten
FDR einen Hinweis darauf, dass der Einﬂuss der Variablen auf den klinischen Endpunkt
zu gering ist und/oder dass die gegebene Stichprobengröße zu gering ist um die gegebenen
Eﬀekte zu ﬁnden.
Sichwörter: Variablenselektion; False Discovery Rate; Receiver Operating Characteris-
tic Curve; Kreuzvalidierung
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D R-Code
This is a R-program for the cross validation procedure to construct a score for future prediction.
The program calculates the optimal choice of the FDR (αˆopt), the corresponding selection bound-
ary (γˆopt), the estimated number of true null hypotheses (pˆi0), the cross validated ÂUC(αˆopt)
as well as the weights of the determined prediction score and the corresponding identiﬁcation
number of the variables included in the prediction score.
Note that with this R-program we search for the optimal estimate of the selection boundary
γ instead of the optimal FDR because of the extremely longer runtime needed to search for the
corresponding γ values in each training set. For the ﬁnally chosen selection boundary the FDR
can be estimated with Storey's estimator in the total sample. Note that searching for the optimal
FDR and γ asymptotically leads to the same (see Storey et al. (2004)), the similarity of outcome
being aﬃrmed by simulations also in our ﬁnite case.
Functions:
crossvalsub ... subroutine of crossvalfun: calculation of function CFij (see Section 4.1.)
fdrestt ... Function to compute the estimate of FDR and the estimate of the number
of true null hypotheses pi0
crossvalfun ... Function to compute cross validated results for a given data set
Parameters:
daten ... data set: one column for each patient, one row for each gene/protein
group ... vector containing 0 or 1 identifying each patient either as responder or
non-responder
gamma1 ... grid of γ values in which the optimal γˆopt should be searched.
Defalt= seq(0.005, 0.5, 0.005)
sided ... if sided=1 a one-sided test is performed, if sided=2, a two-sided test will
be performed for selection of variables for the prediction score. Defalt=1
known ... if known=0 the variance will be assumed as unknown. If the variance is
known, the input is a vector containing the within-group variances for each
gene. Defalt=0
lambda ... Parameter λ for Storeys estimate (see Storey (2002)). Defalt=0.5
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Output:
A list of 3 Items:
CrossValAUC ... includes the cross validated ÂUC(γ) for each of the investigated γ values
in the grid
SelectedHyp ... gives the identiﬁcation numbers of variables included in the score and the
corresponding weights
CrossValResult ... gives the estimate of the optimal choice of the selection boundary, γˆopt, the
corresponding FDR, αˆopt, and the estimated proportion of true null
hypotheses (pi0) as well as the cross validated ÂUC(γˆopt) of the estimated
selection boundary and the number of variables selected for the score.
R-Code:
crossvalsub<-function(parms,daten,rimat,nrimat,tcrit,resp,nresp,n1,n2,known,m,sided)
{
i<-parms[1]
j<-parms[2]
meanr<-rimat[1:m,i]
meannr<-nrimat[1:m,j]
meandiﬀ<-meanr-meannr
if(length(known)==1)
{
varr<-rimat[(m+1):(2*m),i]
varnr<-nrimat[(m+1):(2*m),j]
ssq<-((n1-2)*varr+(n2-2)*varnr)/(n1+n2-4) }
else
{
ssq<-known
}
tstat<-meandiﬀ/sqrt(ssq*(1/(n1-1)+1/(n2-1)))
if(sided==2)tstat<-abs(tstat)
rloi<-daten[,resp[i]]
nrloi<-daten[,nresp[j]]
weight<-outer(tstat,tcrit,">")*(meandiﬀ/ssq)
scorer<-rloi%*%weight
scorenr<-nrloi%*%weight
(scorer>scorenr)+(scorer==scorenr)*0.5
}
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fdrestt<-function(tst,tcrit,gamma1,lambda,ilambda,n1,n2)
{
pi0estim<-min(sum(tst<ilambda)/((1-lambda)*length(tst)),1)
c(min(pi0estim*gamma1*length(tst)/(max(sum(tst>tcrit),1)),1),pi0estim)
}
crossvalfun<-function(daten,group,gamma1=seq(0.005,0.5,0.005),sided=1,known=0,lambda=0.5)
m<-nrow(daten)
fact<-ifelse(sided==1,1,1/2)
resp<-c(1:length(group))[group==0]
nresp<-c(1:length(group))[group==1]
n1<-length(resp)
n2<-length(nresp)
allcomb<-cbind(rep(c(1:n1),n2),sort(rep(c(1:n2),n1)))
tsumr<-apply(daten[,resp],1,sum)
tsumnr<-apply(daten[,nresp],1,sum)
rimat<-(tsumr-daten[,resp])/(n1-1)
nrimat<-(tsumnr-daten[,nresp])/(n2-1)
if(sum(known)==0)
{
tcrit<-qt(1-gamma1*fact,df=(n1+n2-2))
ilambda<-qt(lambda,df=(n1+n2-2))
tqsumr<-apply(daten[,resp]*daten[,resp],1,sum)
tqsumnr<-apply(daten[,nresp]*daten[,nresp],1,sum)
rimat<-rbind(rimat,(tqsumr-daten[,resp]*daten[,resp]-rimat*(n1-1)*rimat)/(n1-2))
nrimat<-rbind(nrimat,(tqsumnr-daten[,nresp]*daten[,nresp]-nrimat*(n2-1)*nrimat)/(n2-2))
}
else
{
tcrit<-qnorm(1-gamma1*fact)
ilambda<-qnorm(lambda)
}
}
crossvalresult<-apply(allcomb,1,crossvalsub,daten,rimat,nrimat,tcrit,resp,nresp,n1,n2,known,m,sided)
{
resultj<-apply(crossvalresult,1,sum)
tmax<-tcrit[resultj==max(resultj)]
tmax<-max(tmax)
gammamax<-gamma1[tcrit==tmax]
resultj<-resultj/(n1*n2)
resultj<-rbind(gamma1,resultj)
rownames(resultj)<-c("gamma","jackknife AUC")
meanr<-tsumr/n1
meannr<-tsumnr/n2
if(sum(known)==0)
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{
varrt<-(tqsumr-tsumr2/n1)/(n1-1)
varnrt<-(tqsumnr-tsumnr2/n2)/(n2-1)
ssqt<-((n1-1)*varrt+(n2-1)*varnrt)/(n1+n2-2)
}
else
{
ssqt<-known
}
meandiﬀt<-meanr-meannr
tstatt<-meandiﬀt/sqrt(ssqt*(1/n1+1/n2))
if(sided==2){tstatt<-abs(tstatt)}
weight<-meandiﬀt/ssqt
sel<-c(1:m)[tstatt>tmax]
weightr<-weight[sel]
result1<-rbind(sel,weightr)
rownames(result1)<-c("Nr. sel. Hyp.","weight")
result2<-c(gammamax,fdrestt(tstatt,tmax,gammamax,ilambda,lambda),max(resultj),length(sel))
names(result2)<-c("opt choice gamma","opt choice FDR","opt choice pi0","cross validated AUC(opt
gamma)","Number of selected Hyp")
erg<-list(CrossValAUC=resultj,SelectedHyp=result1,CrossValResult=result2)
erg
}
Examples:
Construction of a random data set:
n1<-10
n2<-20
m<-1000
delta<-0.4
fhyp<-10
daten<-matrix(rnorm((n1+n2)*m),ncol=(n1+n2),nrow=m)
daten[1:fhyp,1:n1]<-daten[1:fhyp,1:n1]+delta
Identiﬁcation of groups of responders and non-responders:
group<-c(rep(0,n1),rep(1,n2))
Example 1: sided=1, known=0: Selection using one-sided tests assuming unknown
variance:
ex1<-crossvalfun(daten,group,gamma1=seq(0.005,0.6,0.005))
plot(ex1[[1]][1,],ex1[[1]][2,],ylim=c(0,1),xlab=expression(hat(gamma)),
ylab=expression(widehat(AUC)(hat(gamma))))
ex1
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Example 2: sided=1, known=0: Selection using one-sided tests assuming unknown
variance:
ex2<-crossvalfun(daten,group,sided=2,gamma1=seq(0.005,0.6,0.005))
plot(ex2[[1]][1,],ex2[[1]][2,],ylim=c(0,1),xlab=expression(hat(gamma)),
ylab=expression(widehat(AUC)(hat(gamma))))
ex2
Example 3: sided=1, known=rep(1,1000): Selection using one-sided tests assum-
ing known variance 1 for each variable:
ex3<-crossvalfun(daten,group,sided=1,known=rep(1,1000),gamma1=seq(0.005,0.6,0.005))
plot(ex3[[1]][1,],ex3[[1]][2,],ylim=c(0,1),xlab=expression(hat(gamma)),
ylab=expression(widehat(AUC)(hat(gamma))))
ex3
Example 4: sided=2, known=rep(1,1000): Selection using two-sided tests assum-
ing known variance 1 for each variable:
ex4<-crossvalfun(daten,group,sided=2,known=rep(1,1000),gamma1=seq(0.005,0.6,0.005))
plot(ex4[[1]][1,],ex4[[1]][2,],ylim=c(0,1),xlab=expression(hat(gamma)),
ylab=expression(widehat(AUC)(hat(gamma))))
ex4
129
Leer
Bibliography
Abramovich, F., Benjamini, Y., Donoho, D. and Johnstone, I. (2006). Adapting
to unknown sparsity by controlling the false discovery rate.
The Annals of Statistics, 34: 584653.
Anderson, T. (2003). An introduction to multivariate statistical analysis.
Wiley series in probability and statistics, third edition.
Bamber, D. (1975). The area above the ordinal dominance graph and the area below
the receiver operating characteristic graph.
Journal of Mathematical Psychology, 12: 387415.
Bauer, P. (2008). Adaptive designs: looking for a needle in the haystack - a new challenge
in medical research. Statistics in Medicine, 27:15651580.
Bauer, P., Pötscher, B. and Hackl, P. (1988). Model selection by multiple test
procedures. Statistics, 19: 3944.
Benjamini, Y. and Hochberg, Y. (1995). Controlling the false discovery rate - a
practical and powerful approach to multiple testing.
Journal of the royal statistical society, Series B, 57: 289300.
Benjamini, Y. and Yekutieli, D. (2001). The control of the false discovery rate in
multiple testing under dependency.
The Annals of Statistics, 29: 11651188.
Callow, M., Dudoit, S., Gong, W., Speed, T. and Rubin, E. (2000). Microarray
expression proﬁling identiﬁes genes with altered expression hdl-deﬁciont mice.
Genomom Research, 10: 20222029.
Dudoit, S., Shaffer, J. and Boldrick, J. (2003). Multiple hypothesis testing in
microarray experiments. Statistical Science, 18: 71103.
Eaves, I., Wicker, L., Ghandour, G., Lyons, P., Peterson, L., Todd, J. and
Glynne, R. (2002). Combining mouse congenic strains and microarray gene expression
analyses to study a complex trait: the nod model of type 1 diabetes.
Genome Research, 12: 232243.
Genovese, C. and Wasserman, L. (2004). A stochastic approach to false discovery
control. The Annals of Statistics, 32: 10351061.
Goll, A. (2008). Inference on a large number of hypotheses based on limited samples -
some points to consider. Doctoral Thesis.
131
Bibliography
Goll, A. and Bauer, P. (2008). Model selection based on the false discovery rate
optimizing the area under the receiver operating characteristic curve. submitted.
Golub, T., Slonim, D., Tamayo, P., Huard, C., Gaasenbeek, M., Mesirov, J.,
Coller, H., Loh, M., Downing, J., Caligiuri, M., Bloomfield, C. and Lan-
der, E. (1999). Molecular classiﬁcation of cancer: class discovery and glass prediction
by gene expression monitoring. Science 286: 531537.
Han, A. (1987). Non-parametric analysis of generalized regression model. the maximum
rank correlation estimator. Journal of Econometrics, 35: 303316.
Hanley, J. and McNeil, B. (1982). The meaning and use of the area under a receiver
operating characteristic curve. Radiology, 143: 2936.
Harrel, F. (2001). Regression modeling strategies. Springer Series in Statistics.
Hastie, T., R., T. and Friedman, J. (2001). The elements of statistical learning.
Springer Series in Statistics.
Hommel, G. (1988). A stage-wise rejective multiple test procedure based on a modiﬁed
bonferroni test. Biometrica 75: 383386.
Jeffery, I., Higgins, D. and Culhane, A. (2006). Comparison and evaluation of
methods for generating diﬀerentially expressed genes lists from microarray data.
BMC Bioinformatics 7: 359375.
Li, L. and Hui, S. (2007). Step-wise variable selection and positive false discovery rate
estimate in pharmacogenetics studies.
Journal of Biopharmaceutical Statistics, 17: 883902.
Mann, H. and Whitney, D. (1947). On a test of whether one of two random variables
is stochastically larger than the other.
The Annals of Mathematical Statistics, 18: 5060.
Miller, A. (2002). Subset selection in regression. Chapmann and Hall/CRC, second
edition.
Ntzani, E. and Ioannidis, J. (2003). Predictive ability of DNA microarrays for cancer
outcomes and correlates: an empirical assessment. Lancet, 362: 14391444.
Pavlidis, P., Li, Q. and Noble, W. (2003). The eﬀect of replication on gene expression
microarray experiments. Bioinformatics, 13: 16201627.
Pepe, M. (2003). The statistical evaluation of medical tests for classiﬁcation and predic-
tion. Oxford University Press.
Pepe, M., Cai, T. and Longton, G. (2006). Combining predictors for classiﬁcation
using the area under the receiver operating characteristic curve.
Biometrics, 62: 221229.
132
Bibliography
Pepe, M., Janes, H., Longton, G., Leisenring, W. and Newcomp, P. (2004).
Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic or
screening marker. American Journal of Epidemiology, 159: 882890.
Pepe, M. and Thompson, M. (2002). Combining diagnostic test results to increase
accuracy. Biostatistics, 1: 123140.
R (2005). R development core team: A language and environment for statistical comput-
ing. R Foundation for Statistical Computing, Vienna, Austria.
Sachs, L. (1999). Angewandte Statistik: Anwendung statistischer Methoden.
Springer Verlag.
Shao, J. (1993). Linear model selection by cross-validation.
Journal of the american statistical association, 88: 486494.
Sherman, R. (1993). The limiting distribution of the maximum rank correlation esti-
mator. Econometrics, 93: 123137.
Simes, R. (1986). An improved bonferroni procedure for multiple tests of signiﬁcance.
Biometrica, 73: 751754.
Storey, J. (2002). A direct approach to false discovery rate.
Journal of the royal statistical society, Series B, 64: 479498.
Storey, J., Taylor, J. and Siegmund, D. (2004). Strong control, conservative point
estimation and simultaneous conservative consistency of false discovery rates: a uniﬁed
approach. Journal of the royal statistical society, Series B, 66: 187205.
Su, J. and Liu, J. (1993). Linear combinations of multiple diagnostic markers.
Journal of the American Statistical Association, 88: 13501355.
Tian, E., Zhan, F., Walker, R., Rasmussen, E., Ma, Y., Barlogie, B. and
Shaughnessy, J. (2003). The role of wnt-signaling antagonist dkk1 in the development
of osteolytic lesions in multiple myeloma.
New England Journal of Medicine, 26: 24832494.
133
